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Abstract 
 
 
Objectives: to evaluate rural pharmacy practice in Western Australia (WA) (“2006 
data”), and to perform a time-series comparison with the previous data (“2002 data”) 
that were sourced from the National Pharmacy Database Project in 2002.  
 
Methods: a questionnaire used in the 2006 survey was developed based on that used 
in the 2002 national survey. In the 2002 survey, questionnaires were mailed to 1391 
representative participant pharmacies (82 participants from rural WA), of which 
1131 were returned (66 respondents from rural WA). The response rate for rural WA 
was 80.5%. In the 2006 survey, questionnaires were mailed to all 103 sample 
pharmacies of rural WA, of which 51 were returned. This gave a response rate of 
49.5%. Chi-square tests were used to test individual associations between year of 
survey against pharmacist or pharmacy characteristics, or provision of services. 
Where significant associations were reported between year of survey and provision 
of particular services, logistic regressions controlling for gender, age, PhARIA 
location, and inclusion of a forward pharmacy area, were performed.  
 
Results: pharmacist characteristics were not significantly different across the two 
surveys with regard to age, gender, year of registration, qualification, Continuing 
Professional Education (CPE) involvement, and position. Similar pharmacy 
characteristics were reported in relation to PhARIA, setting, group membership, 
inclusion of counselling areas, method of operation, trading hours and annual 
turnover. Only Quality Care Pharmacy Program (QCPP) accredited-pharmacies 
significantly increased. In both surveys, WA rural pharmacies offered a range of 
services, including prescription-related activities, medication reviews, preventive 
services, primary health care, harm minimisation services, and Enhanced Pharmacy 
Services (EPS). A significantly higher percentage of pharmacies provided clinical 
testing for monitoring, Domiciliary Medication Management Reviews (DMMRs), 
and printed information for non-prescribed medicines. There were marked increases 
in weight testing and weight management services. Smoking cessation was offered 
by over 50% of pharmacies, and tended to increase. However, other EPS (asthma, 
diabetes, hypertension, hyperlipidaemia), which correspond to the National Health 
Priorities Areas (NHPAs) and rural needs, were reported by less than 50% of 
pharmacies in both surveys. A shortage of pharmacy workforce still remained a 
problem, as evidenced by similar numbers of full-time equivalent (FTE) pharmacists 
per pharmacy. This study also highlights several issues, including less CPE 
involvement, low uptake of forward pharmacy, and low participation in the S100 
scheme. 
 
Conclusions: This study found a remarkable consistency of WA rural pharmacy 
practice across the two surveys. However, significant increases were reported in 
some important services such as weight management. This findings may indicate that 
support for important services is required if they are to be taken up by the profession. 
The government and pharmacy bodies need to address the workforce barriers to 
improve access to pharmacy services for rural communities. 
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Chapter 1: INTRODUCTION 
 
 
1.1. Background 
Australia is very much an urban society where only approximately 30% of the 
population lives in rural and remote areas.1,2  According to the Australian Institute of 
Health and Welfare (AIHW) 20063, the health status of rural populations in Australia 
is commonly perceived as being poorer than those living in urban areas. This is likely 
to be the result of factors such as higher levels of socio-economic disadvantage 
(lower incomes and lower levels of education), poorer access to health services, 
higher levels of personal health risk factors such as obesity and smoking, and 
environmental issues related with road travel and occupation. The substantial 
proportion of Indigenous people in rural and remote areas, coupled with their poor 
overall health,  also influences the higher mortality rates in these areas.3 
 
Pharmacy is a crucial part of any health care system and plays an important role in 
maintaining the health of all Australians.4 A national survey (2002)5 demonstrated 
that apart of their dispensing role, Australia’s community pharmacies performed a 
range of other services involving medicines and health, such as harm minimisation 
services, medication reviews, and health promotion. The model of pharmacy practice 
in rural settings, however, could be quite different to urban practice. Such major 
cities are provided with high levels of support, and access to a range of health care 
providers.6 Several authors have reported that rural pharmacies provide a greater 
diversity of health care services than their metropolitan counterparts.7-9 These 
services include early intervention and health promotion programs such as 
cholesterol, blood glucose and blood pressure screening, infant health clinics and 
smoking cessation programs.8, 10 Furthermore, pharmacies were highly valued 
amongst rural populations. A survey of rural communities in Western Australia 
(WA) demonstrated that pharmacies were highly utilised for a wide range of health-
based requirements such as emergency treatment, over-the-counter (OTC) and 
prescription medications.11 When small rural communities were asked about health 
care needs in order to keep them healthy, pharmacy services were rank third, only 
after doctors and hospitals.12  
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However, many issues may hamper the provision of pharmacy services in rural areas. 
Financial issues are identified as one of the major barriers. Business overheads may 
be higher as the result of the isolated nature of rural practice. If the higher costs are 
shifted to consumers and can not be afforded, businesses may be under financial 
pressure and pharmacies could be forced to close. This may affect the accessibility to 
pharmacy services, particularly since many rural towns have only a single 
pharmacy.13 The  other  important issue  is  the  shortage  of  pharmacists  in  rural  
areas.8, 9, 14, 15 Emerson14 has discussed the ramifications of this workforce shortage, 
including closure of pharmacies due to lack of staff and the ageing workforce, a 
reduced ability to provide additional professional services, reduction in the quality of 
locum staff, reduced access to Continuing Professional Education (CPE), and doubts 
about the financial viability of rural pharmacies. All of these constraints may result 
in compromising the health of rural Australia.  
 
In addressing these issues, in 2001, the Australian Government introduced a range of 
incentive and support programs designed to prevent rural pharmacy closures and 
increase the number of pharmacies operating in rural areas. Specifically, $60.4 
million was allocated to provide assistance to rural pharmacies over a four-year 
period, under the programs of the Rural Pharmacy Maintenance Allowance, Start Up 
Allowance, Succession Allowance and Allowance for Pharmacist Support Services 
to Remote Area Aboriginal Health Services.4 Moreover, the government has 
provided programs to improve recruitment and retention rates of rural and remote 
pharmacists. For example, the Rural and Remote Pharmacy Workforce Development 
Plan (RRPWDP) established in 1999 includes an attempt to develop a rural 
pharmacy curriculum and makes funds available for undergraduate scholarships for 
students with rural backgrounds, internship and professional development 
allowances.14, 16 Clearly, these efforts were put forward in recognition of the 
important role of pharmacies in the health care system, particularly in rural areas. 
 
Given the significant role of pharmacies in rural health and the poorer health status 
of rural populations, a better understanding of rural pharmacy practice is of 
importance. The national survey (2002)5 constructed the first database of pharmacy 
practice in Australia and, hence, data on rural pharmacy practice could be generated 
from this database. However, more up-to-date data are needed to enable a time-series 
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comparison that provides information on the changes in rural pharmacy practice over 
time. This will assist the government and pharmacy bodies in designing policies and 
programs aimed at improving access to pharmacy services and, therefore, reducing 
rural health inequalities.  
 
 
1.2. Objectives 
1. To provide more recent data in rural pharmacy practice in Western Australia 
(WA) with regard to pharmacist demographics, pharmacy characteristics, 
provision of services, and barriers of providing services; and 
2. To evaluate the changes in WA rural pharmacy practice over a period of four 
years since the previous study in 2002 (the National Pharmacy Database Project 
2002, which included data on WA rural pharmacies). 
 
 
1.3. Significance 
This study was undertaken to identify if rural pharmacy practice in WA had changed 
over a four-year period since 2002 in relation to pharmacist demographics, pharmacy 
characteristics, provision of services, and barriers for providing services. Hence, the 
findings of this study would provide direction for policies and programs to be 
developed to improve the delivery of particular services, particularly those that 
correspond to rural needs. 
 
 
1.4. Definition of Terms 
Comprehensive medication review is defined as a systematic evaluation of a 
resident’s or patient’s complete medication treatment regimen in the context of other 
clinical information and the resident’s or patient’s health status.17 Home Medicines 
Reviews (HMRs) or Domiciliary Medication Management Reviews (DMMRs) refer 
to medication reviews in domiciliary settings.17 
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Consumer Medicine Information (CMI) is brand-specific, manufacturer-produced 
written information about drug products that conforms to special provisions set out in 
the Therapeutic Goods Regulations. 17  
 
Dose Administration Aids (DAAs) are devices or packaging systems designed to 
improve compliance by clearly setting out the medicine doses according to the time 
of administration.18  
 
Enhanced Pharmacy Services (EPS) refer to those offered in community 
pharmacies requiring additional or special skills, knowledge and/or facilities and are 
provided to sub-groups with special needs. They exclude prescription-related and 
over-the-counter (OTC) medicines-related activities. 5, 17 
 
Forward pharmacy is a private unenclosed front-of counter seated area in the 
pharmacy with a dispensary computer for prescription receipt, and counselling for 
medicines or health.19  
 
PhARIA (Pharmacy Access/Remoteness Index of Australia) is a classification 
system designed to provide measurement of the physical and professional remoteness 
of pharmacies within Australia, for use in determining additional remuneration of 
rural and remote pharmacies based on their remoteness.20 
 
Quality Use of Medicines (QUM) constitutes three main activities: (i) selecting 
treatment options wisely (use of medicines only when necessary with non-medicinal 
alternatives considered); (ii) choosing appropriate medicines if a medicine is 
considered necessary (taking into account medical conditions, risks and benefits, 
dosage and length of treatment, duration and costs); and (iii) using medicines safely 
and effectively to achieve the best possible outcomes.21 
 
Rural in this study is used when referring to areas outside metropolitan zones.  
 
Rural pharmacies are defined here as community pharmacies with non-
metropolitan postcodes. 
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Section 100 (S100) involves a community pharmacy that supplies medicines to a 
remote area Aboriginal Health Service (AHS) through arrangements made under 
section 100 of the National Health Act. They may also provide assistance in the 
implementation of procedures and protocols, including development of a medicine 
store, assisting AHS staff with stock control and medication management 
procedures, providing continuing education, and assisting clinical staff in AHS with 
clinical enquiries, and other medicine issues.22, 23 
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Chapter 2: LITERATURE REVIEW 
 
 
 Rural Society, Health and Health Services 
 Rural Society  
People who live outside major cities live in a range of settings that could broadly be 
categorised as rural, regional, and remote areas. The generic term ‘rural’, however, is 
often used when referring to these areas generally.24 Several systems have been 
developed to classify areas according to their rurality. Three major rurality 
classifications are currently used: (i) RRMA (Rural, Remote and Metropolitan Areas) 
classification; (ii) ARIA (Accessibility/Remoteness Index of Australia) 
classification; and (iii) ASGC (Australian Standard Geographical Classification) 
Remoteness Areas.25  
 
In 2001, it was reported that 34% of the Australian population lived in rural and 
remote areas.1 Rural population growth varied across areas and was strongly 
concentrated in areas relatively close to the edges of major urban centres, suggesting 
that what is actually occurring is a new form of quasi-urbanisation. It is noted that 
small rural communities in the wheat and sheep belt have been steadily losing 
population due to the departure of young adults. This gradual decline is associated 
with the loss of many commercial and public services, which makes small towns 
even less attractive.26  
 
While some parts of the rural areas are indeed in demographic decline, others are 
growing rapidly, and hence there is considerable diversity. The key factors that 
influence demographic diversity include: (i) fertility – the extent to which women 
living in the area have children; (ii) mortality – the pattern of death in the sector; and 
(iii) in and out migration – the extent to which people move into or out of the area. 
All of these factors vary in different parts of the rural areas.6, 26 
 
Throughout the 1990s, rural organisations began to respond to the rural decline and 
they developed significant political influence. Rural issues have been prominent in 
political life and there has been a significant political response. The Australian 
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Government has invested millions of dollars into rural developments in many forms. 
Hence, it is important to acknowledge that the broad diversity across rural Australia 
translates into a diversity of needs. The policy relevant to a small rural community 
that serves wheat-farming areas that are in decline will differ markedly to those 
relevant to a prosperous wine-growing area that is booming.26 The lack of 
understanding of the issues from a rural perspective may lead to inappropriate 
responses in addressing rural inequalities. 
 
2.1.2. Rural Health  
The health of rural populations in Australia is commonly perceived as being poorer 
than those living in urban areas. It was reported that rural populations have higher 
mortality and hospitalisation rates for some diseases.2, 3, 6 Many factors may 
contribute to the rural health disadvantage, which include: (i) poorer access to health 
care; (ii) higher levels of socio-economic disadvantage; (iii) higher levels of health 
risk factors, (iv) greater exposure to injury; and (v) Indigenous health needs.2, 3 
 
Rural populations tend to have less access to health care. This is indicated by the 
lower levels of health care personnel and health services available in rural areas. 
Medicare data also have shown that people living in rural areas are using less 
services than those living in urban areas.2 Despite health access issues, rural residents 
have been reported as experiencing higher levels of socio-economic disadvantage 
than their metropolitan counterparts, as evidenced by the SEIFA (Social and 
Economic Index for Australia) score.2 SEIFA is a set of indexes calculated to provide 
information on the level of socio-economic well-being on a geographic basis. The 
three indicators calculated from the 1991 Census were ‘Economic resources’, 
‘Education and occupation’, and ‘Disadvantage’. All showed a pattern of increasing 
disadvantage with increasing distance from major urban centres.2, 6  
 
The 2001 National Health Survey revealed that health risk factors tend to be worse in 
rural areas compared to metropolitan areas. For example, males in regional areas 
were 1.33 times as likely to engage in risky alcohol consumption as those in major 
cities. Also, people in regional areas were 1.11 times as likely to smoke as people in 
major cities, and were less likely to walk for exercise. Moreover, males and females 
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in regional areas were, respectively, 1.05 and 1.10 times as likely to be overweight or 
obese as their major cities counterparts.1 These factors are likely to increase the risk 
of cardiovascular and respiratory diseases, cancers, and diabetes.1, 6   
 
The large contribution of farming and mining to rural life is associated with a greater 
incidence of injuries.6 An estimated 20 to 60 presentations to the rural emergency 
department occur per 100 farms per year.27 Rural residents are also more likely to be 
exposed to high-speed, long-distance motor travel and unsealed roads, all of which 
are related with the higher risk of injury. It was reported that the incidence of road 
crashes in rural areas is estimated to be almost twice that in urban areas.28 
 
In 2001, Indigenous Australians made up 2.4% of the national population, and an 
estimated 70% of them live in rural and remote areas.1 It was reported that 
Indigenous people suffer a mortality rate two to three times higher than other 
Australians, with a life expectancy twenty or more years shorter.3, 26 High levels of 
socio-economic disadvantage (lower incomes, higher rates of unemployment, and 
poorer education achievements), high exposure to violence, and high levels of health 
risk behaviour such as smoking and obesity, all drive these extraordinary 
differentials. 3, 26 Hence, the substantial Indigenous population in rural and remote 
areas, coupled with their inferior health status, significantly affects rural health in 
general. 
 
2.1.3. Rural Health Services 
The most defining features of rural health services is reduced access compared with 
the cities.2 Since many small, isolated communities lack sufficient population to 
sustain a local service, residents may have a limited choice of health services in their 
areas, and may be required to seek care from large centres.6 It was acknowledged 
that rural people recognise the need to travel further for access to services, especially 
for specialist consultations.2, 6 Hence, the great distance to services, coupled with a 
limited choice of services, tends to make access to health care more difficult, 
expensive and time consuming for rural people.29  
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Access is even more problematic due to workforce shortages resulting in fewer 
health professionals per population.6, 30 There are significantly more residents per 
full-time equivalent (FTE) general practitioners (GPs) in metropolitan zones (985 to 
1085 people per GP) than non-metropolitan areas (1206 to 2524 people per GP). 
However, it was reported that rural people have fewer visits to GPs.6, 31 Travelling 
long distances to reach a GP is likely to be one factor explaining the lower use of 
GPs in rural areas. Another potentially significant factor is cost, as rates of bulk-
billing are lower in the country.6, 32 Similar inequalities occur in terms of access to 
pharmacies, hospitals, and specialists.26  
 
It is acknowledged that access to, and use of, health services are significant factors 
contributing to optimising the health status of rural Australians. Hence, it is 
important to develop alternative models for delivering more effectively an 
appropriate level and mix of health services.6 There is a range of alternative models 
of care, including Multipurpose Centres and Multipurpose Services, mobile services, 
visiting services, and telemedicine.33-35 The rationale of Multipurpose Centres and 
Multipurpose Services is to maximise the range of local health services in a cost-
effective way through better coordination across health services and the sharing of 
limited resources.36 Mobile services and visiting services are taking services to 
patients and, therefore, overcome the issue of patient transport. Telemedicine uses an 
interactive audiovisual system that enables diagnosis, treatment, and many other care 
activities across vast distances. This provides a cost-effective way of delivering 
health care without the need for rural people to travel. Given that alternative models 
of service delivery have their own advantages and disadvantages, it is important that 
their adoption takes into account the specific circumstances and health needs of the 
community.6 
 
 
2.2. Pharmacy Services 
Traditionally, community pharmacies have been the main suppliers of medicines for 
the Australian population. However, this role has evolved, with a proliferation of 
professional services.37 The development of professional services is believed to be 
important for pharmacy to survive as a profession, and to maximise its contribution 
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to community health care. It has been indicated that there are less expensive and 
probably more efficient ways of supplying medications than by almost exclusively 
using pharmacists.38, 39 Hence, pharmacists are expected to provide their customers 
with value-added services rather than just supply medicines. Shepperd40 suggested 
that ‘…. in the future, more people and organisations will choose a pharmacy not so 
much on product price, but on the package of values that accompanies the product’.  
 
According to Engle41, professional services will enhance the community pharmacy 
practice base, improve therapeutic outcomes for patients, increase pharmacists’ job 
satisfaction, and provide new sources of revenue. Moreover, the development of a 
service orientation is important for ensuring the quality use of medicines (QUM).37 
QUM constitutes three main platforms: (i) selecting treatment options wisely (use of 
medicines only when necessary with non-medicinal alternatives considered); (ii) 
choosing appropriate medicines if a medicine is considered necessary (taking into 
account medical conditions, risks and benefits, dosage and length of treatment, 
duration and costs); and (iii) using medicines safely and effectively to achieve the 
best possible outcomes.21  
 
Through both the traditional role of supplying medicines and an evolving role in the 
provision of professional services, community pharmacy makes a significant 
contribution to the care of patients, the health of individuals who directly come to 
pharmacists to ask for advice, and prevention public health more broadly. A 
systematic review of the literature published since 1990 on pharmacist professional 
services has demonstrated that there is considerable high-quality evidence to support 
the value of professional services in the community setting.42  
 
Several studies have been carried out with regard to the provision of services in 
Australia’s community pharmacies. A review of national and jurisdictional surveys 
of community pharmacies conducted in Australia since 1970, by government 
agencies, national and state pharmacy bodies, and university researchers summarised 
the activities of community pharmacists into two categories: (i) prescription-related 
activities; and (ii) other health-related services, including primary health care, self 
care and health promotion.43 
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In 1992, a survey of community pharmacies within Western Australia was conducted 
to document the scope and nature of pharmaceutical services offered for the 
elderly.38 Investigators found a range of services with high levels of first-aid 
assistance, health information provision and incontinence counselling; but low levels 
of monitoring (such as blood glucose levels), and advice (such as therapeutic drug 
levels or blood cholesterol levels). Few respondent pharmacists reported having 
evaluated the effectiveness (9%) or the efficiency (4%) of services provided.38, 44 The 
results of this study provided insight into the range of activities performed in 
community pharmacies. 
 
The National Pharmacy Database Project, which was conducted in 2002, provided 
the first national database of Australia’s community pharmacies with regard to 
pharmacy characteristics, and the provision of services. It was reported that 
Australia’s community pharmacies performed a wide range of services, including 
prescription-related activities, primary health care (including OTC medications), 
medication reviews, preventive services, harm minimisation, complementary 
therapies and Enhanced Pharmacy Services (EPS).5  
 
Prescription-related Activities 
Prescription-related activities are referred to those associated with dispensing of 
prescribed medicines, which include: (i) assessment of the medicine prescribed 
(taking into account patients’ other medication and their medical condition); (ii) 
supplying of the correct medicine; (iii) appropriate labeling and recording; and (iv) 
patient counselling on their medication.17 Aside from verbal counselling, pharmacists 
provide written counselling, including Consumer Medicine Information (CMI), as a 
supplement. CMI is brand-specific, manufacturer-produced written information 
about drug products that conforms to special provisions set out in the Therapeutic 
Goods Regulations. All prescription and “pharmacist-only” medicines required CMI 
to be provided by 2004.17 Some patients may require Dose Administration Aids 
(DAAs) in addition to counselling.17 DAAs are devices or packaging systems 
designed to improve the compliance of consumers by clearly setting out the medicine 
doses according to the time of administration. The use of DAAs in medication 
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management is supported by literature and survey evidence collated by Australian 
researchers.18 
 
Medication Reviews 
In Australia, a simple medication review is carried out at the time a medicine is 
dispensed without the benefit of specific clinical information. Comprehensive 
medication review refers to a systematic evaluation of a resident’s or patient’s 
complete medication treatment regimen in the context of other clinical information 
and the resident’s or patient’s health status. This process involved pharmacists with 
special skills and knowledge, to support and assist other health professionals to 
ensure the QUM.17 Pharmacies have been able, from 1997, to engage and be 
remunerated for pharmacists accredited by the Australian Association of Consultant 
Pharmacy (AACP) or the Society of Hospital Pharmacists of Australia to perform 
comprehensive  medication  reviews in  residential  aged  care  facilities,  and  since 
1 October 2001 to perform medication reviews in domiciliary settings (Home 
Medicines Reviews or HMRs – also known as Domiciliary Medication Management 
Reviews or DMMRs).45 The 2002 national survey reported that 24.5% and 19.7% of 
pharmacies respectively provided DMMRs and medication management reviews in 
aged care facilities.5 
 
Primary Health Care  
Primary health care is provided by health workers, including GPs and pharmacists, 
who form the first level of contact with health systems. It was documented that 
community pharmacy has been an active primary health care provider in Australia 
since the 19th century.46 Australia has standards and guidelines for pharmacists in 
assisting self-medication by consumers, providing CMI, GPs’ and pharmacists’ 
interprofessional communication, and the provision of “pharmacy” (Schedule 2 −  
S2) and “pharmacist-only” (Schedule 3 − S3) medicines in community pharmacy.17  
 
Preventive Services 
Community pharmacies are highly suited to health promotion as a high volume of 
people use their services.47 Australia has standards and guidelines for pharmacists to 
assist self-medication by consumers, to provide CMI, to provide “pharmacy” (S2) 
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and “pharmacist-only” (S3) medicines, and to perform clinical testing (such as blood 
glucose and blood pressure measurements) for screening and monitoring purposes.17 
Moreover, the Royal Australian College of General Practitioners (RACGP) 
guidelines, which identify the level and strength of evidence of the preventive 
activities recommended for general medical practice in Australia,48 are generally 
applicable to preventive activities in Australia’s community pharmacies. The 2002 
national survey demonstrated that pharmacists were undertaking a large variety of 
preventive activities, including initiating OTC agents for preventive purposes, and 
performing screening tests. More than 50% of pharmacies performed blood pressure 
measurements, and a lower percentage provided blood glucose, blood cholesterol, or 
weight testing at least one test per month.49 
 
Harm Minimisation Services 
In the 1980s, harm minimisation referred mainly to methadone and needle or syringe 
programs, but then the term “harm reduction” has broadened to efforts that reduced 
the adverse health effects and socio-economic consequences of illicit drugs without 
necessarily reducing their consumption.50 Community pharmacies have many 
attributes that make them important in minimising harm associated with drug misuse. 
For example, the geographical distribution of and opening hours of pharmacies make 
them more accessible to the public, and the daily dispensing and supervision of 
methadone enables them not only to manage opioid dependence, but also prevent the 
diversion of methadone.49 In Australia, the standards for pharmacists in management 
of licit opioids use are set down in state and national regulations and guidelines.17, 51 
Surveys of methadone programs involving Australia’s community pharmacies were 
first performed in 1996 by Victoria’s Turning Point group.52 In 1999 and 2000, 
Curtin University pharmacy researchers managed a series of studies in five of 
Australia’s jurisdictions, which reported high patient acceptability of pharmacies in 
community methadone programs, the characteristics of participating pharmacists and 
pharmacies, the retention of clients in methadone programs, costs in public and 
private clinics, and factors affecting the prevention and treatment of drug misuse.53 
The national survey in 2002 found that more than 40% of Australia’s community 
pharmacies were active in each of methadone or buprenorphine dosing, or needle 
exchange.5 
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Enhanced Pharmacy Services (EPS) 
EPS refer to health-related services other than supplying medicines that require 
additional or particular skills, knowledge and/or facilities and are provided to sub-
groups with special needs.5, 17 In Australia, many of these services such as wound 
management and smoking cessation, are recognised, defined, and described for 
implementation in community pharmacies.17 The 2002 national survey reported that 
over 40% of Australia’s community pharmacies offered EPS in each of the areas of 
asthma, diabetes, harm reduction with methadone, herbal medicines counselling, 
hypertension, and wound care. Other services that offered by 20% to 40% of 
pharmacies included community education, geriatric care, naturopathy, pain 
management osteoporosis, skin care, and weight reduction management. This study 
also highlighted the barriers of providing EPS, including lack of time, a shortage of 
pharmacists, no extra remuneration, or the inability to find locums.5, 54 
 
 
2.3. Rural Pharmacy  
2.3.1.   Rural Pharmacy as Health Care Provider 
The PhARIA (Pharmacy Access/Remoteness Index of Australia) system has been 
developed to provide a comprehensive, standardised measurement of remoteness of 
pharmacies throughout Australia. This system incorporates measurements of the 
physical remoteness (as represented by road distance to reach a range of services), 
and professional isolation (as represented by the road distance to the five closest 
pharmacies). There are six categories within this classification, which include: (i) 
highly accessible, (ii) accessible (Group A); (iii) accessible (Group B); (iv) 
moderately accessible; (v) remote; and (vi) very remote.20 
Pharmacy plays an important role in maintaining the health of rural populations as 
access to other health care in these areas is often limited.55 In small towns, the 
presence of pharmacies allowed that population to have easy access to a wider range 
of pharmacy services. Pharmacies also enjoyed a higher level of community support 
than the local medical services. This was evidenced by pharmacies being highly 
utilised for OTC, emergency, and prescription medications.11 When small rural 
communities were asked about health care needs in order to keep them healthy, 
 Chapter 2: Literature Review 15
pharmacy services were ranked third, only after doctors and hospitals.12 1 A recent 
study has shown that these preferences have not changed substantially after almost a 
decade.56  
 
The pharmacy is often the first point of contact for the rural population, perhaps due 
to its ease of access and non-threatening image.8, 10 People can come to a pharmacy 
without an appointment, can expect to receive professional help almost immediately, 
and retain a high level of control over the extent of their engagement with the 
pharmacist.37  
 
Further, pharmacists have been the most frequently contacted of Australia’s 
community health workers.43 A quantitative study showed that the overall rate of 
people receiving services in Australia’s community pharmacies was approximately 
4.8 million per fortnight, comprising of 3.2 million prescription-related contacts and 
1.6 million other health related contacts.43 People perceive pharmacists as highly 
reliable advisers on many personal health matters, trustworthy independent 
purveyors of health care products, and steadfast partners of the medical profession. 
This has been clearly demonstrated in national and international literature on 
consumers’ views and experiences of community pharmacy services.57  
 
2.3.2.  Rural Pharmacy Practice 
Some authors have reported that rural pharmacists provide a greater diversity of 
health care compared to their urban counterparts. These services included early 
intervention and health promotion programs and services such as cholesterol, blood 
glucose and blood pressure screening, infant health clinics and smoking cessation 
programs.8, 10 Another study showed that rural pharmacists were more involved in 
providing professional services such as intensive education of diabetic patients with 
regard to the proper use of home serum glucose monitors, and of asthmatic patients 
with regard to proper inhaler use.58 When rural and remote pharmacists in New 
South Wales (NSW) were asked about the perceived differences between rural and 
urban pharmacy practice, they believed that they were involved in a lot more 
diagnosing and extended services than their urban colleagues. They also believed 
that rural pharmacists develop stronger relationships with their patients and with 
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other health care professionals, which provide benefits to the overall health of the 
patients.59 
 
It could be argued that, because of the relatively poor levels of health and health 
services experienced by rural populations, it is more important for rural pharmacists 
to offer this wider range of health services than their urban counterparts. Researchers 
believe that rural pharmacies should work closely with local doctors and other health 
professionals in order to provide a comprehensive health care.60-62 Hence, 
multidisciplinary team is the preferred model of care in rural areas as it improves 
health outcomes through better coordination of health professionals and the sharing 
of limited resources.6, 29 Such multidisciplinary teams have been utilised in the 
provision of Multipurpose Services, Coordinated Care Services and Aboriginal 
health, which collectively aim to improve overall community health by specifically 
targeting medication and disease management while maintaining continuity of care 
for patients.63  
 
Despite the greater diversity of services provided, pharmacists in rural areas carry a 
heavier workload with lower economic rewards than experienced by their urban 
colleagues.64 A study conducted in Nebraska found that 33.0% of rural pharmacists 
worked more than 50 hours per week compared to 23.8% of urban pharmacists.65 
This is in line with the findings of Australia’s Pharmacy Labour Force Survey 
(2001)66. The fact that many rural pharmacies are staffed by a single pharmacist may 
contribute to this situation as these pharmacists have to work longer hours to 
complete the maximum recommended daily workload by themselves.14 This situation 
is even worse due to difficulties in finding relief coverage and sufficient professional 
staff in rural areas.13, 67  
 
2.3.3.  Issues Related with Rural Pharmacy Practice 
While pharmacy plays an important role in improving rural health, there are many 
issues that may hamper the provision of pharmacy services.  
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Geographical Issues 
Research by Kaiser68 demonstrated that the location of pharmacies in Western 
Australia was less than optimal, in terms of accessibility for the entire population. It 
was estimated that Western Australians had to travel an average distance of 5.7 
kilometers to the nearest pharmacy; however, rural residents must travel longer 
distances to reach a pharmacy. Clearly, this finding indicates that rural residents have 
not received the same level of access to pharmacy services. 
 
A survey comparing pharmacy services in single and no pharmacy towns showed 
that participants in no pharmacy towns were more likely to be dissatisfied with the 
level of health and pharmacy services access they were receiving. The most salient 
features of this dissatisfaction were having to travel to access medications and not 
being able to immediately access medications from the doctor’s dispensary. More 
non-pharmacy town participants thought they were receiving inadequate advice on 
medicines.69  
 
Geographic access to health services, however, was considered as a less serious 
problem, suggesting that distance has been accepted as part of rural living. Rural 
consumers perceived the cost of health services and higher prices than in urban areas 
was the major issue.70 A study on access to pharmacy services in three rural states in 
the United States indicated that financial access to pharmacy services for rural 
consumers was a serious concern, especially for the elderly who lack prescription 
drug coverage.67 
 
Economic/Financial Issues 
Financial issues are identified as one of the major barriers for the provision of 
pharmacy services in rural areas. The cost of doing business and overheads may be 
higher because of the isolated nature of rural pharmacies, increased competition from 
mail-order companies, and discriminatory pricing on the part of drug manufacturers. 
This may produce further problems if the higher costs are shifted to consumers, since 
the rural population tends to have lower incomes than urban residents. If these higher 
prices can not be afforded, businesses may be under pressure and pharmacies may be 
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forced to close. This may affect the accessibility to health services, since many rural 
towns have only a single pharmacy.13 
 
Workforce Issues 
It is well documented that there is an under-supply of pharmacists in Australia, and 
this is more pronounced in rural areas of Australia than in metropolitan areas.8, 9, 14, 15 
For the year 2000, there were 359 pharmacies in metropolitan WA (each servicing 
3923 people), and 110 pharmacies in rural WA (each servicing 4572 people).71 This 
indicates that pharmacists in rural WA served more people than their urban 
counterparts. 
 
In a qualitative study, Emerson14 identified several major causes for this 
maldistribution of pharmacists in rural areas. The widespread shortage of FTE 
pharmacy staff available was cited as the major cause. The second perceived cause 
was the notion that there is a general refusal of pharmacists to move to rural settings. 
Several reasons were cited for this attitude. The first was the increasing number of 
females in the pharmacy workforce. It is believed that female pharmacists are more 
likely to work part-time and are less likely to own pharmacies. Female pharmacists 
also tend to work where their spouse is working, which is often in metropolitan 
areas. It is also believed that the high percentage of recent graduates from non-
English speaking backgrounds can influence the rural workforce as their family and 
social ties are mostly metropolitan based, making them less inclined to move away.14  
 
Emerson14 has discussed the ramifications of this misdistribution, including closure 
of pharmacies due to lack of staff and the ageing workforce, a reduced ability to 
provide additional professional services, reduction in the quality of locum staff, 
reduced access to Continuing Professional Education (CPE), and doubts about the 
financial viability of regional pharmacies. These constraints can make access to 
pharmacy services even more complicated, and may result in compromising the 
health of rural Australia. 
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In addressing the rural health issues, in 2001, the government introduced a range of 
incentive and support programs designed to prevent rural pharmacy closures and 
increase the number of pharmacies operating in rural areas. Specifically, $60.4 
million was allocated to provide assistance to rural pharmacies over a four-year 
period, under the programs of the Rural Pharmacy Maintenance Allowance, Start Up 
Allowance, Succession Allowance, and Allowance for Pharmacist Support Services 
to Remote Area Aboriginal Health Services.4  
 
Moreover, the government has provided programs to improve recruitment and 
retention rates of rural and remote pharmacists. For example, the Rural and Remote 
Pharmacy Workforce Development Plan (RRPWDP) established in 1999 includes an 
attempt to develop a rural pharmacy curriculum and make funds available for 
undergraduate scholarships for students with rural backgrounds, internship and 
professional development allowances.14, 16 It is believed that a rural background and 
positive rural experiences, such as undergraduate rural placements, internship years, 
and other rural educational experiences, seem to influence the decision of 
pharmacists to practice and to remain working in rural areas.14, 16, 59 The RRPWDP 
has also partially addressed the emergency relief coverage by implementing an 
“Emergency Locum Service” to find and cover the travel costs for locums in 
emergency situations.72 As many rural pharmacies are staffed by a single pharmacist, 
in emergency situations such as illness or bereavement, pharmacies often have been 
forced to close temporarily, compromising the health of rural people.72 Clearly, these 
efforts were put forward in recognition of the important role of pharmacies in the 
health care system, particularly in rural areas. 
 
Given the poorer health status of rural populations and the significant role of 
pharmacies in improving rural health, a better understanding of the rural pharmacy 
practice is very important. The national survey (2002)5 constructed the first database 
of pharmacy practice in Australia and, thus, data on rural pharmacy practice could be 
generated from this database. However, more up-to-date data are needed to enable a 
time-series comparison that provides information on the changes in rural pharmacy 
practice over time. This will assist the government and pharmacy bodies in designing 
policies and programs aimed at improving access to pharmacy services and, hence, 
reducing rural health inequalities. 
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Chapter 3:  METHODS 
 
 
3.1.  Study Design 
A cross-sectional mail survey was designed to provide recent data (“2006 data”) in 
rural pharmacy practice in WA, and to enable a time-series comparison with the 
previous data (“2002 data”). The source of the previous data was Australia’s 
National Pharmacy Database Project5, which was a national survey of community 
pharmacies performed in 2002. 
 
 
3.2.  Ethics 
This study was approved by the Human Research Ethics Committee (HREC) of 
Curtin University of Technology on 19th October 2006 [Appendix 1]. All sample 
pharmacies were informed about the study, and the respondent pharmacies were 
requested to provide written informed consent.   
 
All of the data collected was de-identified, processed and analysed in groups, and 
held confidentially according to National Health and Medical Research Council 
(NHMRC) requirements. On the completion of the study, the data will be stored in a 
secure place at the School of Pharmacy for a period of seven years. 
 
 
3.3.  Questionnaire 
The  questionnaire,  which  was  used  in  the  2006  survey,  consisted  of  9  pages, 
4 sections (A to D), and 32 questions [Appendix 2].  The questionnaire was designed 
based on that used in the Australia’s National Pharmacy Database Project (2002) 5, so 
that comparisons could be made over time. There were, however, some questions 
that were modified from the 2002 questionnaire to suit rural situations [Table 3.1]. 
These questions were not used in the time-series comparison.  
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Table 3.1. The questions comprising the 2006 questionnaire and the matched 
questions from the 2002 questionnaire 
Sections and Questions Question no. (2006) 
Question no. 
(2002) 
A : Respondent pharmacy details 
Age 1 1 
Gender 2 2 
Year of registration 3 3 
Rural background 4 N/A 
Highest qualification 5a 5a 
Continuing Professional Education (CPE) 5b, 5c 5b, 5c 
Position in pharmacy 6 6 
B : Pharmacy services 
Prescription-related activities   
Number of prescriptions 7a 10a 
Category of order 7b N/A 
Delivery method 7c N/A 
Dose Administration Aids (DAAs) 8 11a 
Supervised dosing 9 11c 
Declined prescription 10 12 
Counselling 11 13a 
Monitoring 12, 13 13b, 13c 
Impact of Silver Chain or Nursing Post 14 N/A 
Medication Review Processes   
Supply medicines to aged care facilities 15a, 15b 14a, 14b 
HIC registration 15c 14c 
Medication review processes 15d 14d 
Australian Association of Consultant Pharmacy 
(AACP)-accredited pharmacists 
 
15e, 15f 
 
14e, 14f 
Preventive services   
Preventive activities with non-prescribed 
medicines 
 
16 
 
17 
Screening tests 17 18 
Primary health Care (S2 and S3) 18 15a 
Harm minimisation services 19 19a 
Complementary therapies 20 20 
Enhanced Pharmacy Services (EPS) 21 7 
C : Barriers and facilitators 
Barriers to EPS 22 8 
Facilitators for EPS 23 9 
D : Pharmacy characteristics 
Postcode (PhARIA) 24a 25a 
Setting 24b N/A 
Hours and days open per week 25 25c 
Structure of premises 26 26 
Group membership 27 27 
Quality Care Pharmacy Program (QCPP) status 28 28 
Method of operation 29a, 29b 29a, 29b 
Pharmacy staff  – working hours per week  30 32 
Number of customer per week 31 N/A 
Total turnover 32a 33a 
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3.4.  Sample 
The national survey (2002)5 involved a population of all pharmacies registered in 
Australian jurisdictions for the 12 months to December 2001 (4824 pharmacies). 
Stratification with the PhARIA system was used to minimise sampling bias arising 
from location. Due to 81% of the total pharmacies being in PhARIA 1, a 20% 
random sample of total PhARIA 1 pharmacies was drawn. Due to the small number 
of pharmacies in PhARIA 2 to 6, the entire population was used.  Overall, this gave a 
total sample of 1641 pharmacies [Table 3.2]. Of the sample of 1641 pharmacies, 
1391 agreed to participate, 141 refused, and 109 were not contactable due to 
duplications or pharmacy closure. Questionnaires were mailed to the 1391 
participants [Table 3.2], of which 82 were participant pharmacies from rural WA 
[Table 3.3]. Only data from WA rural pharmacies were included in the time-series 
comparison. 
 
Table 3.2. Sample and participant pharmacies across Australia by PhARIA (2002) 
PhARIA Number of  Australia’s pharmacies Sample Participants 
1 3927 744 611 
2 321 321 278 
3 313 313 276 
4 123 123  110 
5 and 6 140 140 116 
Total 4824 1641 1391 
 
Table 3.3. Participant pharmacies from rural WA by PhARIA (2002) 
PhARIA Participants (rural WA) 
1 4 
2 17 
3 17 
4 14 
5 16 
6 14 
Total 82 
 
In the 2006 survey, the population was all pharmacies in rural WA (103 pharmacies) 
as listed by the Pharmaceutical Council of Western Australia (PCWA) in September 
2006 [Appendix 3]. Due to the small number of rural pharmacies in WA, the whole 
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population was used. The sample pharmacies were then classified, using the PhARIA 
system, into six categories [Table 3.4].  
 
Table 3.4. Sample pharmacies from rural WA by PhARIA (2006) 
PhARIA Number of  WA rural pharmacies  Sample 
1 18 18 
2 16 16 
3 17 17 
4 14 14 
5 18 18 
6 20 20 
Total 103 103 
 
 
3.5.  Procedure 
Three consecutive mailings of the questionnaire were implemented in the 2002 
national survey. The 1391 participant pharmacies, including 82 rural WA 
participants, were first mailed the questionnaire on 12th of July 2002, with two 
subsequent mail outs at approximately 20 day intervals to non-respondents in July 
and August to increase the response rate.5  
 
A similar procedure was applied in the 2006 survey. The questionnaires were first 
mailed to the 103 sample pharmacies (rural WA) on the 19th of October 2006. Two 
subsequent mailings were sent on 10th and 24th of November for non-respondents. A 
cover letter (introducing the study and requesting participation from the pharmacies) 
[Appendix 4], a consent form, and a stamped-addressed envelope, were included in 
each mailing. The cut off date for questionnaires to be returned was 17th of 
December 2006.  
 
 
3.6.  Data Analysis 
Statistical analysis of data was performed using the SPSS statistical software package 
for Windows (Version 14.0). Frequencies and percentages of responses were 
generated for each question from the 2006 questionnaire, and for matched questions 
from the 2002 questionnaire. If responses were continuous and numerical, 
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descriptive statistics were generated (mean, standard deviation, median, minimum 
and maximum score). 
 
Cross tabulations by year of survey (2002 and 2006) were conducted for questions of 
“pharmacist characteristic” (section A), “pharmacy characteristic” (section D), and 
“service” (section B). The data from “service” questions were first combined (within 
questions) to create an overall binary variable (“Not providing the service” versus 
“Providing the service”).  
 
To test individual associations between year of survey against pharmacist or 
pharmacy characteristics, or provision of services, Pearson chi-square tests were 
conducted (where expected cases were less than five, Fisher’s exact test were 
calculated). Where significant associations were reported from the chi-square tests 
between year of survey and provision of particular services, logistic regressions were 
performed. Due to the limited sample size, only a few factors were included in the 
logistic regression to control for any effects between year of survey and frequency of 
service provision. Four “characteristic” variables (gender, age, PhARIA location, and 
inclusion of a forward pharmacy area) were selected as analysis from 2002 indicated 
that those variables may influence service provision.5, 54, 73  
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Chapter 4: RESULTS 
 
 
4.1. Response Rate 
Response rate refers to the number of pharmacies that returned their questionnaire 
(“respondent”) as a proportion of those that were sent the questionnaires 
(“participant” in the 2002 survey, or “sample” in the 2006 survey).  
 
In the National Pharmacy Database Project (2002)5, of the total sample of 1641 
pharmacies (a census sample of PhARIA 2 to 6 and a 20% random sample of 
PhARIA 1 pharmacies), 1391 agreed to participate, 141 refused, and 109 were not 
contactable due to duplications or pharmacy closure. Questionnaires were mailed to 
1391 participant pharmacies (including 82 participants from rural WA), of which 
1131 were returned (including 66 respondents from rural WA). The overall response 
rate for rural WA in the 2002 survey was 80.5% (66/82).  
 
In the 2006 survey, questionnaires were mailed to all 103 sample pharmacies (a 
census sample of all rural pharmacies in WA, including a small number of PhARIA 1 
rurally located pharmacies), of which 51 were completed and returned. The overall 
response rate of this study was therefore 49.5% (51/103). The comparisons of 
response rates for rural WA by PhARIA and by year of survey are detailed [Table 
4.1].  
 
Table 4.1. Response rates for rural WA by PhARIA and by year of survey  
Rural WA (2002) Rural WA (2006) 
Participants Respondents Response rates Sample Respondents 
Response 
rates PhARIA 
N N  %  N  % 
1 4 3  75.0 18 6  33.3 
2 17 14  82.3 16 12  75.0 
3 17 16  94.1 17 7  41.1 
4 14 13  92.8 14 6  42.8 
5 16 11  68.7 18 10  55.5 
6 14 9 64.3 20 10 50.0 
Total 76 66  80.5 103 51 49.5 
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4.2.  Respondent Pharmacist Details 
Of 66 respondent pharmacies from rural WA in the 2002 survey, the proportion of 
males was larger than females (66.7% versus 33.3%, respectively). This figure had 
changed in the 2006 survey where almost the same proportion of males and females 
were reported among a total of 51 respondents (51.0% and 49.0%, respectively) 
[Table 4.2]. The Pearson chi-square test, however, showed that there was no 
association between year of survey and gender (χ2 (1) = 2.945, P = 0.086).  
Table 4.2. Characteristics of WA rural respondent pharmacists by year of survey 
Respondents (2002) Respondents (2006) Characteristics N  (%) N  (%) P-value
a 
 
Gender   0.086 
Male 44  (66.7) 26  (51.0)  
Female 22  (33.3) 25  (49.0)  
Age   0.598 
≤ 50 years 49  (74.2) 40  (78.4)  
51+ years 17  (25.8) 11  (21.6)  
Year of registration   0.278 
Pre-1970 14  (21.5) 7  (13.7)  
1970 and afterward 51  (78.5) 44  (86.3)  
Highest qualification   0.556 
Diploma 14  (21.2) 7  (13.7)  
B Pharm 47  (71.2) 39  (76.5)  
Other 5  (7.6) 5  (9.8)  
Continuing Pharmacy 
Education (CPE)   
0.626 
≤ 10 hours/month 56  (84.8) 44  (88.0)  
> 10 hours/month 10  (15.2) 6  (12.0)  
Position in the pharmacy   0.745 
Sole proprietor 34 (53.1) 24 (47.1)  
Partner proprietor 16  (25.0) 12  (23.5)  
Manager 9  (14.1) 8  (15.7)  
Other pharmacist staff 5  (7.9) 7  (13.8)  
a P-value from Pearson chi-square tests 
 
Similar figures were reported for age, degree and year of registration between 2002 
and 2006 respondents [Table 4.2]. Of respondents in the 2002 survey, 74.2% were 
less than 50 years of age, and 71.2% held a university bachelor degree reflecting 
graduates mainly since 1970. While in 2006, 78.4% of respondents were less than 50 
years of age, 76.5% had a bachelor degree, and 86.3% registered as a pharmacist in 
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1970 and afterward. Additionally, more than 70% of the respondents in both surveys 
were the pharmacy’s proprietors. Over 80% of the respondents in the 2002 and 2006 
surveys spent less than 10 hours per month on Continuing Pharmacy Education 
(CPE), with less than 10% not taking part in any CPE in the past year (9.1% and 
6.0%, respectively).  
 
 
4.3.  Pharmacy Characteristics 
Of a total 66 WA rural pharmacies in the 2002 survey, 50% of pharmacies were from 
“smaller towns” (PhARIA 4 to 6), and 50% were from “larger towns” (PhARIA 1 to 
3). A similar trend was reported in 2006 where about the same percentage of a total 
51 pharmacies were from “smaller towns” or “larger towns” (49.0% versus 51.0%, 
respectively) [Table 4.3]. The majority of pharmacies in 2006 were located in stand 
alone or strip shopping centres (54.9%), and had between 501 and 1500 customers 
per week (52.9%). These figures, however, were not directly comparable to 2002 
figures, since different categories were applied for these particular questions. 
 
In the 2002 and 2006 surveys, more than half of the pharmacies were owner operated 
(58.5% and 64.7%, respectively), and had group memberships (60.0% and 51.0%, 
respectively) [Table 4.3]. The percentage of pharmacies with Quality Care Pharmacy 
Program (QCPP) accreditation more than doubled from 2002 to 2006  (41.5% versus 
86.3%, respectively). The Pearson chi-square test showed that there was a significant 
association between year of survey and whether or not pharmacies were QCPP 
accredited (χ2 (1) = 24.087, P < 0.001). 
 
More pharmacies in 2006 grossed over $2 million compared to those in 2002 (45.0% 
versus 29.2%, respectively) [Table 4.3]. The estimate means of the turnovers for 
2002 and 2006 were: $1.71 million (SD = 1.18) and 1.93 million (SD = 1.31), 
respectively. However, in order to make a more accurate comparison, the 2002 figure 
should be adjusted for inflation rates. Based on the Consumer Price Index (CPI) 
200674, the inflation rates in Australia were as follows: 3.0% (period 2002-03); 1.9% 
(period 2003-04); 2.0% (period 2004-05); and 3.3% (period 2005-06). Thus, the 
adjusted estimate mean of the 2002 turnover was $1.89 million.  
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It was reported that only a small percentage of pharmacies in 2002 and 2006 had a 
forward pharmacy (15.6% and 12.2%, respectively; P = 0.610) or a closed 
counselling/dosing area (31.3% and 36.7%, respectively; P = 0.541) [Table 4.3]. 
Forward pharmacy referred to a private unenclosed front-of counter seated area in 
the pharmacy with a dispensary computer for prescription receipt, and counselling 
for medicines or health. 
 
Table 4.3. Characteristics of WA rural pharmacies by year of survey 
WA rural pharmacies 
(2002)  
WA rural pharmacies 
(2006) Characteristics 
N  (%) N  (%) 
P-valuea 
 
PhARIA   0.355 
1 3  (4.5) 6  (11.8)  
2 14  (21.2) 12  (23.5)  
3 16  (24.2) 7  (13.7)  
4 13  (19.7) 6  (11.8)  
5 11  (16.7) 10  (19.6)  
6 9  (13.6) 10  (19.6)  
 
Setting of pharmacy N/A  N/A 
Stand alone or strip 
shopping centre 
 
28  (54.9) 
 
Shopping mall complex  17  (33.3)  
Medical centre  6  (11.8)  
Hospital  0  (0.0)  
 
Pharmacy areas   
 
Forward area   0.610 
Yes 10 (15.6) 6 (12.2)  
No 54 (84.4) 43 (87.8)  
Unenclosed 
counselling/dosing area   
 
0.701 
Yes 49 (76.6) 39 (79.6)  
No 15 (23.4) 10 (20.4)  
Closed 
counselling/dosing area   
 
0.541 
Yes 20 (31.3) 18 (36.7)  
No 44 (68.8) 31 (63.3)  
 
Group   
 
0.331 
No group 26  (40.0) 25  (49.0)  
In a group  39  (60.0) 26  (51.0)  
 
QCPP status  
 
<0.001 
Not QCPP accredited  38  (58.5) 7  (13.7)  
Partially completed  27  (41.5) 44  (86.3)  
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Method of operation  
 
0.642b 
Owner operated 38  (58.5) 33  (64.7)  
Partner operated 15  (23.1) 7  (13.7)  
Manager operated 10  (15.4) 9  (17.6)  
Other 2  (3.1) 2  (3.9)  
 
Non-pharmacist retail 
manager 
 
 
 
0.209 
Yes 18  (28.1) 20  (39.2)  
No 46  (71.9) 31  (60.8)  
 
Customer weekly N/A  N/A 
< 500  11  (21.6)  
501-1000  15  (29.4)  
1000-1500  12  (23.5)  
1501-2000  8  (15.7)  
2001-3000  3  (5.9)  
3001+  2  (3.9)  
 
Annual turnover 
  
N/Ac 
< $1 m 18  (27.7) 14  (27.5)  
$ 1 – 1.5 11  (16.9) 9  (17.6)  
$ 1.5 – 2 17  (26.2) 5  (9.8)  
$ 2 – 3 13  (20.0) 15  (29.4)  
$ 3 – 4 4  (6.2) 4  (7.8)  
$ 4 – 6 1  (1.5) 4  (7.8)  
$ 6 – 8 1  (1.5) 0  (0.0)  
$ 8+ 0  (0.0) 0  (0.0)  
a  P-value from Pearson chi-square test 
b P-value from Fisher’s exact test 
c Estimate means were used for comparison to enable adjustment for inflation rate 
 
Pharmacies in both surveys opened six days per week (median) for approximately 50 
hours (median) [Table 4.4]. The median was used because data were not normally 
distributed as confirmed by the Shapiro-Wilk test (P <0.05).  
 
Table 4.4. WA rural pharmacies’ opening hours and days per week by year of survey 
 WA rural pharmacies  (2002) 
WA rural pharmacies 
(2006)  
Total days per week  N = 61 
Mean          6.2  
SD              0.41 
Median       6.0 
N = 50 
Mean        6.2  
SD            0.51 
Median     6.0 
Total hours per week N = 62 
Mean          52.6  
SD              11.71 
Median       50.0 
N = 50 
Mean       53.2  
SD           10.26 
Median    51.0 
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4.4.  Pharmacy Services 
4.4.1.  Prescription-related Activities 
The majority of WA rural pharmacies in 2002 and 2006 dispensed less than 800 
prescriptions in a week (58.4% and 58.8%, respectively) [Table 4.5].  
 
Table 4.5. Prescriptions dispensed in WA rural pharmacies by year of survey 
WA rural pharmacies 
(2002) 
WA rural pharmacies 
(2006) Prescriptions weekly 
N (%) N (%) 
0 to 300 9 (13.8) 13 (25.5) 
301 to 800 29 (44.6) 17 (33.3) 
801 to 1,200 17 (26.2) 10 (19.6) 
1,201 to 2,000 9 (13.8) 11 (21.6) 
2,001 to 3,000 1 (1.5) 0 (0.0) 
3,001 or more 0 (0.0) 0 (0.0) 
 
Many rural pharmacies in 2002 and 2006 provided DAAs to a number of facilities 
[Table 4.6]. In both surveys, it was reported that more than 75% of pharmacies 
provided DAAs in community settings, and lower percentages of pharmacies 
provided DAAs to nursing homes or hostels. The proportion of pharmacies supplying 
DAAs for remote clinics had more than doubled from 2002 to 2006. However, only 
23 pharmacies responded to the “remote clinics” question in the 2006 survey, and 
this resulted in a much higher percentage for the 2006 figure, which was 34.8% 
(8/23). 
 
Table 4.6. WA rural pharmacies by various facilities where DAAs being issued and 
by year of survey  
Active pharmacies  
(2002)  
Active pharmacies  
(2006) Aged or community setting 
N (%) N (%) 
Nursing home 21 (35.0) 21 (45.7) 
Hostel 32 (52.5) 20 (46.5) 
Community 50 (78.1) 46 (90.2) 
Remote clinics 6 (13.0) 8 (34.8) 
 
It appears that 41 pharmacies (63.1%) in the 2002 survey and 29 pharmacies (59.2%) 
in the 2006 survey performed supervised dosing of at least one of the five drugs 
included in the surveys [Table 4.7]. Methadone was reported as the most common 
drug being supervised by pharmacies in the 2002 and 2006 surveys (54.0% and 
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45.8%, respectively). This was followed by buprenorphine (30.2%) and 
benzodiazepines (28.0%) in the 2006 survey; and benzodiazepines (30.9%) and 
analgesics (26.8%) in the 2002 survey. 
 
Table 4.7. WA rural pharmacies by a range of drugs being supervised and by year of 
survey 
Active pharmacies  
(2002)   
Active pharmacies  
(2006)  Drugs 
N (%) N (%) 
Analgesics 15 (26.8) 7 (15.9) 
Benzodiazepines 17 (30.9) 12 (28.0) 
Buprenorphine 10 (18.5) 13 (30.2) 
Methadone 34 (54.0) 22 (45.8) 
Other psychotropics 9 (17.6) 5 (12.5) 
Other agents 4 (10.0) 3 (13.0) 
 
CMI was provided in a computerised form by more than 90% of pharmacies in both 
surveys. Over 70% of pharmacies in 2002 and 2006 provided written information 
produced by computer programs other than CMI (76.3% and 82.0%, respectively), or 
other written or printed information (81.7% and 74.5%, respectively). About 68% of 
pharmacies provided counselling to non- or poor-English speaking patients in both 
surveys [Table 4.8].  
 
More than 75% of pharmacies counselled patients in an unenclosed area in 2002 and 
2006 (77.4% and 90.2% respectively). Over 30% of pharmacies provided counselling 
in a closed counselling area, and less than 20% counselled in a forward pharmacy in 
both surveys [Table 4.8].  
 
Table 4.8. WA rural pharmacies by counselling categories and by year of survey 
Active pharmacies  
(2002) 
Active pharmacies  
(2006) Counselling type 
N (%) N (%) 
Poor English 44 (68.7) 35 (68.6) 
CMI computerised information 57 (91.9) 50 (98.0) 
Other computer information 45 (76.3) 41 (82.0) 
Written of printed information 49 (81.7) 38 (74.5) 
Closed area 22 (35.5) 23 (46.0) 
Unenclosed area 48 (77.4) 46 (90.2) 
Forward pharmacy 12 (20.0) 7 (14.0) 
MAS (health insurance) 5 (8.2) 5 (10.0) 
Other 1 (14.3) 4 (57.1) 
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More than 90% pharmacies in 2002 and 2006 reported monitor compliance with 
verbal questioning (98.0% and 92.2%, respectively) or repeat prescriptions (98.0% 
and 93.8%, respectively). DAAs have emerged as devices for enhancing compliance 
with about 80% of pharmacies reporting use of DAAs for monitoring compliance in 
both surveys [Table 4.9].  
 
Most pharmacies monitored patient responses to therapy by questioning patients or 
their carers. The use of methods other than verbal assessment to monitor the effects 
of prescribed therapy [Table 4.10] showed over 80% of pharmacies in both surveys 
using records of adverse effects in patients’ files.  Clinical testing devices (such as 
weight scales, blood pressure and glucose meters) were used by more pharmacies in 
2006 than those in 2002 (78.4% and 59.4%, respectively; χ2 (1) = 4.723, P = 0.030). 
Logistic regression controlling for gender, age, PhARIA location, and the inclusion 
of a forward pharmacy, showed that pharmacies in 2006 were 1.30 times (95%CI = 
1.038 – 1.636) as likely to use clinical testing devices as those in 2002. Less than 
20% of pharmacies in both surveys reported using laboratory results for monitoring 
the effects of drugs.  
 
Table 4.9. WA rural pharmacies by methods of monitoring compliance and by year 
of survey 
Active pharmacies 
(2002) 
Active pharmacies 
(2006)  Method of monitoring compliance N (%) N (%) 
Questions 59 (92.2) 49 (98.0) 
Repeats 61 (93.8) 48 (98.0) 
DAAs 50 (82.0) 44 (88.0) 
Other 3 (30.0) 1 (33.3) 
 
Table 4.10. WA rural pharmacies by methods for assessing drug effects and by year 
of survey 
Active pharmacies 
(2002)  
Active pharmacies 
(2006)  Method of monitoring drug effects N (%) N (%) 
Clinical testinga 38 (59.4) 40 (78.4) 
Laboratory results 5 (7.9) 8 (16.0) 
Adverse effects recorded in 
patient files 53 (82.8) 46 (90.2) 
Other 2 (25.0) 0 (0.0) 
a Using chi-square tests, P < 0.05 
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4.4.2.  Medication Review Processes 
A total of 43 pharmacies (66.2%) and 26 pharmacies (51.0%) respectively reported 
supplying medicines to aged care facilities or private hospitals in 2002 and 2006 
[Table 4.11]. The proportion of pharmacies approved for DMMRs doubled from 
those  approved  in  2002   (30.0% in 2002  versus  64.0% in 2006;  χ2 (2) = 13.407, 
P = 0.001) [Table 4.12].  
 
DMMRs activity showed progress, with 29.8% to 56.3% of pharmacies being 
involved respectively in 2002 and 2006 (χ2 (1) = 7.474, P = 0.006) [Table 4.13]. 
Logistic regression controlling for gender, age, location PhARIA, and inclusion of a 
forward pharmacy, showed that pharmacies in 2006 were 1.36 times (95%CI = 0.730 
– 1.573) as likely to perform DMMRs as pharmacies in 2002. Less than 25% of 
pharmacies in both surveys provided medication reviews in aged care facilities or 
Enhanced Primary Care (EPC) multidisciplinary care plans.  
 
Table 4.11. WA rural pharmacies by status of supplying medicines to aged care 
facilities or private hospitals and by year of survey 
WA rural pharmacies 
(2002)  
WA rural pharmacies 
(2006)  Status 
N (%) N (%) 
Yes  43 (66.2) 26 (51.0) 
No 22 (33.8) 25 (49.0) 
Total 64 (100.0) 51 (100.0) 
 
Table 4.12. Pharmacies by HIC approval for DMMRs and by year of survey 
WA rural pharmacies 
(2002)  
WA rural pharmacies 
(2006)  Approveda 
N (%) N (%) 
Yes 18 (30.0) 32 (64.0) 
No 40 (66.7) 16 (32.0) 
Don’t know 2 (3.3) 2 (4.0) 
Total 60 (100.0) 50 (100.0) 
a using chi-square tests, P < 0.05 
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Table 4.13. WA rural pharmacies by medication review processes and by year of 
survey  
Pharmacies involved 
(2002)  
Pharmacies involved 
(2006) Review Process 
N (%) N (%) 
DMRs or DMMRsa 17 (29.8) 27 (56.3) 
Medication management reviews 
in aged care facilities 12 (21.1) 10 (20.0) 
Enhanced primary care (EPC) 
multidisciplinary care plan 9 (16.7) 7 (15.6) 
Enhanced primary care (EPC) 
case conference 3 (5.6) 4 (8.9) 
Enhanced primary care (EPC) 
case health assessment 1 (1.9) 2 (4.4) 
S100 for Aborigines 4 (7.3) 6 (13.6) 
Other medication reviews 1 (5.0) 1 (14.3) 
a Using chi-square tests, P < 0.05 
 
Pharmacies reported having access to an AACP-accredited pharmacist increased 
from 45.2% of pharmacies in 2002 to 70.6% of pharmacies in 2006 (χ2 (2) = 11.224, 
P = 0.004) [Table 4.14]. The reported position of the AACP-accredited pharmacist in 
pharmacies is recorded in Table 4.15. 
 
Table 4.14. WA rural pharmacies by access to AACP-accredited pharmacists and by 
year of survey 
WA rural pharmacies 
(2002)  
WA rural pharmacies  
(2006)  Access to AACP pharmacistsa 
N (%) N (%) 
Yes 28 (45.2) 36 (70.6) 
No  28 (45.2) 8 (15.7) 
Don’t know 6 (9.7) 7 (13.7) 
Total 62 100.0 51 100.0 
a Using chi-square tests, P < 0.05 
 
Table 4.15. Position held with AACP-accredited pharmacist in WA rural pharmacies 
with access by year of survey 
WA rural pharmacies 
(2002)  
WA rural pharmacies 
(2006)  Position in pharmacy 
N (%) N (%) 
Proprietor 13 (46.4) 10 (27.8) 
Manager 0 (0.0) 2 (5.6) 
Employee full-time 2 (7.1) 1 (2.8) 
Employee part-time 1 (3.6) 3 (8.3) 
Consulted of contracted 11 (39.3) 19 (52.8) 
Other  1 (3.6) 1 (2.8) 
Total 28 (100.0) 36 (100.0) 
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4.4.3. Preventive Services  
The percentage of WA rural pharmacies that reported providing OTC agents for 
primary preventive purposes is presented in Table 4.16. More than 90% of 
pharmacies in the 2002 and 2006 surveys provided nicotine replacement, folic acid 
for pregnancy, calcium, or daily multivitamins for undiagnosed patients. 
 
Table 4.16. WA rural pharmacies by OTC medicines provided for primary 
prevention and by year of survey 
Pharmacies involved (2002) Pharmacies involved (2006)  Preventive OTC N (%) N (%) 
Nicotine replacement 63 (98.4) 47 (94.0) 
Aspirin (≥ 100mg daily) 44 (69.8) 32 (64.0) 
Iron supplementation 55 (85.9) 40 (78.4) 
Folic acid in pregnancy 63 (96.9) 49 (96.1) 
Calcium 62 (95.4) 46 (90.2) 
Daily multivitamins 61 (95.3) 50 (98.0) 
Other 4 (80.0) 4 (80.0) 
 
Data on screening tests performed in WA rural pharmacies in both surveys showed 
that more than 50% of pharmacies performed blood pressure measurements [Table 
4.17]. A lower percentage of pharmacies in both 2002 and 2006 surveys offered 
glucose tests (20.3% and 18.0%, respectively), and cholesterol tests (9.5 and 4.0%, 
respectively). Fewer pharmacies in 2006 provided bone testing than those in 2002 
(15.9% vs. 0.0%, respectively). Interestingly, the prevalence of pharmacies providing 
weight testing increased from 3.2% in 2002 to 44.9% in 2006. The Pearson chi-
square tests showed that there was a significant association between year of survey 
and whether or not pharmacies provided weight testing (χ2 (1) = 28.498, P < 0.001). 
After controlling for gender, age, PhARIA location, and inclusion of a forward 
pharmacy, pharmacies in 2006 were 2.24 times (95%CI = 1.526 – 3.283) as likely to 
provide weight testing as those in 2002.  
 
Table 4.17. WA rural pharmacies by screening tests provided and by year of survey 
Pharmacies involved (2002)  Pharmacies involved (2006) Screening test N  (%) N  (%) 
Anthropometric (weight, etc)a 2  (3.2) 22  (44.9) 
Cholesterol  6  (9.5) 2  (4.0) 
Blood pressure 38  (58.5) 34  (66.7) 
Glucose 13  (20.3) 9  (18.0) 
Bone densityb 10  (15.9) 0  (0.0) 
Pregnancy 5  (7.9) 2  (4.0) 
Other 1  (20.0) 0  (0.0) 
a Using Pearson chi-square test, P < 0.05 
b Using Fisher’s Exact test, P < 0.05 
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4.4.4.  Primary Health Care  
All pharmacies in the 2002 and 2006 surveys were actively involved in self-
medication, and assisting patients with their symptoms or health problems [Table 
4.18]. Printed information, including computerised CMI and Self Care cards, for 
non-prescribed medicines was used by more pharmacies in 2006 compared to those 
in 2002 (92.2% versus 76.6%, respectively). After controlling for gender, age, 
PhARIA location, and inclusion of a forward pharmacy, pharmacies in 2006 were 
1.49 times  (95%CI = 1.069 – 2.074) as likely to provide printed information as those 
in 2002. In both surveys, more than 80% of pharmacies reported having patients 
referred to doctors with ailments, and about 50% of pharmacies made referrals to 
other health care workers [Table 4.18]. 
 
Table 4.18. WA rural pharmacies by primary health care and self-medication 
activities and by year of survey 
Pharmacies involved 
(2002)  
Pharmacies involved 
(2006)  Health care actions 
N (%) N (%) 
Self-medication (named S2 or S3) 63 (100.0) 50 (100.0) 
Primary care (received assistant) 63 (100.0) 50 (100.0) 
Printed information including 
computerised CMI and Self Carea 49 (76.6) 47 (92.2) 
Referred to GPs 54 (84.4) 42 (82.3) 
Referred to other health workers 32 (51.6) 26 (52.0) 
Other  2 (40.0) 2 (100.0) 
a Using Pearson chi-square tests, P < 0.05 
 
4.4.5. Harm Minimisation Services  
Needle supplies were provided by more than 60% of the WA rural pharmacies in 
both surveys. A similar prevalence was evident in the 2002 and 2006 surveys for 
pharmacies involved in methadone dosing (56.9% and 45.1%, respectively), and 
buprenorphine dosing (15.6% and 25.5%, respectively). Benzodiazepine contracts or 
arrangements with prescribers for other drugs of dependence were practised in 42.2% 
and 36.7% of WA rural pharmacies in 2002 and 2006, respectively [Table 4.19]. 
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Table 4.19. WA rural pharmacies by harm reduction activities and by year of survey 
Pharmacies involved 
(2002)  
Pharmacies involved  
(2006)  Activity 
N (%) N (%) 
Methadone dosing 37 (56.9) 23 (45.1) 
Buprenorphine dosing 10 (15.6) 13 (25.5) 
Naltrexone dispensing 5 (8.1) 1 (2.0) 
Needle supply or 
exchange 49 (77.8) 
30 (62.0) 
Benzodiazepine or other 
prescriber contracts 27 (42.2) 18 (36.7) 
Other 5 (31.2) 4 (44.4) 
 
4.4.6. Enhanced Pharmacy Services (EPS) 
The Enhanced Pharmacy Services (EPS) that were offered by WA rural pharmacies 
in the 2002 and 2006 surveys are listed in Table 4.20, along with trained staff, fees 
charged and if services were planned in 12 months.  More than 20% of pharmacies in 
the 2002 and 2006 surveys offered EPS for asthma (31.3% and 23.5%, respectively), 
diabetes (25.0% and 25.5%, respectively), harm reduction with methadone (54.7% 
and 45.1%, respectively), geriatric care (23.4% and 5.9%, respectively), herbal 
medicines/nutritional supplement counselling (59.4% and 47.1%, respectively), 
hypertension (45.3% and 49%, respectively), smoking cessation (51.6% and 62.7%, 
respectively), weight reduction (34.4% and 58.8%, respectively), and wound care 
(49.1% and 45.1%, respectively)  
 
The provision of weight reduction services showed an increase from 22 pharmacies 
(34.4%) in 2002 to 30 pharmacies (58.8%) in 2006. The Pearson chi-square test 
showed that there was a significant association between year of survey and whether 
or not pharmacies provided weight reduction services (χ2 (1) = 6.849, P = 0.009). 
After controlling for gender, age, PhARIA location, and inclusion of a forward 
pharmacy, pharmacies in 2006 were 1.37 times (95%CI = 1.109 – 1.695) as likely to 
provide weight reduction services as those in 2002. Among pharmacies offering 
weight management, it was reported that a higher percentage of pharmacies received 
payment (28.3% versus 18.2%, respectively), and had trained or accredited staff 
(36.7% versus 22.7%, respectively) in 2006 compared to 2002.  
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On the other hand, geriatric care was provided by a lower percentage of pharmacies 
in 2006 than in 2002 (χ2 (1) = 6.625, P = 0.010). After controlling for gender, age, 
PhARIA location, and inclusion of a forward pharmacy, pharmacies in 2006 were 
less likely to provide geriatric care than those in 2002 (odds ratio = 0.690; 95%CI = 
0.493 – 0.966). Of pharmacies offering this particular service in 2002, a similar 
percentage (33.3 %) either received payment or had trained staff, while in 2006, none 
of the pharmacies either received payment or had trained staff for geriatric care.  
 
Structured community education was provided by 16 pharmacies (25.0%) in 2002, 
but this decreased to 4 pharmacies (7.8%) in 2006 (χ2 (1) = 5.815, P = 0.016). After 
controlling for gender, age, PhARIA location, and inclusion of a forward pharmacy, 
pharmacies in 2006 were less likely to provide structured community education than 
those in 2002 (odds ratio = 0.677; 95%CI = 0.493 – 0.932). None of these 
pharmacies received a fee for this particular service. Among pharmacies providing 
this service, a higher percentage of pharmacies had trained staff in 2006 compared to 
that in 2002 (75.0% versus 37.5%, respectively).  
 
For most of the services (asthma, community education, community clinic with 
nurses, diabetes, herbal medicines, naturopathy, hypertension, weight reduction, 
smoking cessation, and wound care), the percentages of pharmacies that had trained 
staff were higher than those that received payment. However, of 35 pharmacies 
(54.7%) and 23 pharmacies (45.1%) respectively providing harm reduction in 2002 
and 2006, the majority received payment (80.0%; and 86.9%, respectively), and 
smaller percentages had trained staff (34.3% and 21.7%, respectively) [Table 4.20].  
 
The following EPS were planned to be introduced by at least 4% of pharmacies in 
the months of July-September 2003: diabetes (15.6%); naturopathy (12.5%); asthma, 
or community education, or community clinic with nurses or herbal medicines, or 
hyperlipidaemia, or hypertension, or smoking cessation (4.7%). In the 2006 survey, 
diabetes or weight reduction or geriatric care was the prominent EPS planned to be 
offered (11.8%); followed by asthma (7.8%), smoking cessation (6.2.%); community 
education, or community clinic services, or herbal medicines, or hyperlipidaemia, or 
naturopathy, or wound care (5.9%) [Table 4.20]. 
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Table 4.20. WA rural pharmacies that offered Enhanced Pharmacy Services (EPS) by 
trained staff, fees charged and planning in 12 months, and by year of survey 
WA rural pharmacies (2002)  WA rural pharmacies (2006)  
Offer Receive payment 
Trained 
staff 
Plan in  
12 months  Offer 
Receive 
payment 
Trained 
staff 
Plan in  
12 months Enhanced pharmacy service N  
(%) 
N 
(%)b 
N 
(%)b 
N 
(%)  
N  
(%) 
N  
(%)b 
N 
(%)b  
N 
(%) 
Aboriginal health 
services 
8 
(12.5) 
6 
(75.0) 
0 
(0.0) 
2 
(3.1) 
 
7 
(13.7) 
3 
(42.8) 
2 
(28.6) 
0 
(0.0) 
Anticoagulation 1 
(1.6) 
0 
(0.0) 
0 
(0.0) 
0 
(0.0) 
 
1 
(2.0) 
1 
(100.0) 
1 
(100.0) 
1 
(2.0) 
Asthma 20 
(31.3) 
0 
(0.0) 
8 
(40.0) 
3 
(4.7) 
 
12 
(23.5) 
0 
(0.0) 
6 
(50.9) 
4 
(7.8) 
Community education, 
structureda 
16  
(25.0) 
0 
(0.0) 
6 
(37.5) 
3  
(4.7) 
 4  
(7.8) 
0  
(0.0) 
3 
 (75.0) 
3 
(5.9) 
Community clinic 
services with nurse 
7  
(10.9) 
1 
(14.3) 
2 
(28.6) 
3  
(4.7) 
 6  
(11.8) 
0  
(0.0) 
3  
(50.0) 
3 
(5.9) 
Diabetes 16 
(25.0) 
0 
(0.0) 
5 
(31.2) 
10  
(15.6) 
 13  
(25.5) 
0  
(0.0) 
5  
(38.0)  
6 
(11.8) 
Drug level monitoring/ 
kinetic dosing 
1  
(1.6) 
0 
(0.0) 
1 
(100.0) 
1  
(1.6) 
 1  
(2.0) 
0  
(0.0) 
0  
(0.0) 
0 
(0.0) 
Harm reduction 
including methadone 
35  
(54.7) 
28 
(80.0) 
12 
(34.3) 
1  
(1.6) 
 23  
(45.1) 
20  
(89.9) 
5  
(21.7) 
1 
(2.0) 
Geriatric carea 15  
(23.4) 
5 
(33.3) 
5 
(33.3) 
2  
(3.1) 
 3  
(5.9) 
0  
(0.0) 
0  
(0.0) 
6 
(11.8) 
Herbal medicines/ 
nutritional supplement 
counselling 
38 
(59.4) 
2 
(5.3) 
13 
(34.2) 
3 
(4.7) 
 
24 
(47.1) 
2 
(3.9) 
10 
(41.7) 
3 
(5.9) 
Hyperlipidaemia 10 
(15.6) 
3 
(30.0) 
0 
(0.0) 
3 
(4.7) 
 
5 
(9.8) 
0 
(0.0) 
1 
(20.0) 
3 
(5.9) 
Hypertension 29 
(45.3) 
6 
(20.7) 
7 
(24.1) 
3 
(4.7) 
 
25 
(49.0) 
4 
(16.0) 
6  
(24.0) 
2 
(3.4) 
Naturopathy 9 
(14.1) 
1 
(11.1) 
3 
(33.3) 
8 
(12.5) 
 
8  
(15.7) 
1 
(12.5) 
3 
(37.5) 
3 
(5.9) 
Smoking cessation 33 
(51.6) 
1 
(3.0) 
12 
(36.4) 
3 
(4.7) 
 
32  
(62.7) 
1 
(3.1) 
10 
(31.2) 
4 
(6.2) 
Weight reductiona 22 
(34.4) 
4 
(18.2) 
5 
(22.7) 
0 
(0.0) 
 
30  
(58.8) 
7 
(23.3) 
11 
(36.7) 
6 
(11.8) 
Wound care 25 
(49.1) 
1 
(4.0) 
5 
(20.0) 
2 
(3.1) 
 
23 
(45.1) 
1 
(4.3) 
9 
(39.1) 
3 
(5.9) 
a Using Pearson chi-square tests, P < 0.05 
b Percentage from  number of pharmacies offered the particular service 
 
In both surveys, the barriers of providing EPS, in order, were lack of time, a shortage 
of pharmacists, no extra remuneration, and the inability to get locum cover for 
emergencies. The barriers most strongly rejected for EPS were “not felt to be part of 
their job” and “it may impair their relations with GPs” [Table 4.21]. 
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Table 4.21. Barriers to EPS reported by WA rural pharmacies by year of survey 
WA rural pharmacies (2002)  WA rural pharmacies (2006) 
Barriers  Strongly disagree – 
Disagree 
Unsure 
Strongly 
agree- 
Agree 
 
Strongly 
disagree - 
Disagree 
Unsure 
Strongly 
agree -
Agree 
Shortage of time for pharmacist 6.2% 3.1% 90.8%  10.0% 4.0% 86.0% 
Shortage of pharmacists 4.7% 7.8% 87.5%  16.0% 12.0% 72.0% 
Customer’s won’t pay 15.4% 30.8% 53.8%  14.0% 30.0% 56.0% 
Unable to get locum cover for 
emergencies 21.9% 10.9% 67.2%  22.0% 16.0% 62.0% 
Lack of appropriate 
knowledge/skills by pharmacists 45.3% 10.9% 43.8%  50.0% 14.0% 36.0% 
Lack of confidence by pharmacy 
staff 48.4% 14.1% 37.5%  48.0% 10.0% 42.0% 
It is not felt by pharmacists to be 
part of their job 78.1% 12.5% 9.4%  74.0% 10.0% 16.0% 
There is no extra remuneration for it 20.3% 10.9% 68.8%  16.0% 14.0% 70.0% 
Would impair working relationships 
with local GPs 55.4% 30.8% 13.8%  58.0% 24.0% 18.0% 
Lack of opportunity to meet with 
local GPs or other health workers 47.7% 13.8% 38.5%  44.0% 16.0% 40.0% 
GPs do not recognise pharmacists’ 
skills in enhanced pharmacy 
services 
35.4% 24.6% 40.6%  34.0% 28.0% 38.0% 
 
In the 2002 survey, the facilitators most strongly supported for EPS were 
“accreditation”, “dedicated study time”, “clinical testing area” and “closed 
counselling area”. A similar figure was reported for the 2006 survey except for 
“clinical testing area” [Table 4.22]. 
 
Table 4.22. Facilitators for EPS reported by WA rural pharmacies by year of survey 
WA rural pharmacies (2002)  WA rural pharmacies (2006) 
Facilitators  Strongly disagree -
Disagree 
Unsure 
Strongly 
agree - 
Agree 
 Strongly 
disagree -
Disagree 
Unsure 
Strongly 
agree - 
Agree 
Access to detailed patient notes 11.1% 17.5% 71.4%  12.0% 20.0% 68.0% 
Designated closed counselling 
area 17.2% 7.8% 75.0% 
 
16.0% 14.0% 70.0% 
Designated clinical testing area 14.1% 7.8% 78.1%  16.3% 26.5% 57.1% 
Appointment system 16.1% 19.4% 64.5%  18.4% 22.4% 59.2% 
Accreditation for specific 
activity 10.9% 10.9% 78.1% 
 8.2% 10.2% 81.6% 
Dedicated study time for 
pharmacist 4.7% 12.5% 82.8% 
 8.0% 16.0% 76.0% 
 
 
 
 Chapter 5: Discussion 41
Chapter 5:  DISCUSSION 
 
 
5.1.   Response Rate 
The response rates for the 2006 survey were lower than those for the 2002 survey, 
particularly for PhARIA 3 and PhARIA 4 pharmacies. Both the 2002 and 2006 
surveys used three consecutive mailings to enhance response rate. However, the 2002 
national survey applied other techniques, including wide publicity of the survey 
(newsletter, journal, and website) and offering incentives (accreditation points and a 
cash payment)5, which were not applied in the 2006 survey. This may reflect the 
effectiveness of the publicity and the incentives in achieving the higher response rate. 
 
 
5.2. Respondent Pharmacist Details 
The 2002 survey respondents from rural WA were mainly owner or partner 
pharmacists who were males, with one-quarter aged 50 years of age or more. 
However, there was a trend of an increasing proportion of females in rural WA over 
time. This may relate to the fact that most new pharmacy workforce entrants are 
females. The Pharmacy Labour Force Survey in 1999 reported that the proportion of 
females in the pharmacist labour workforce had risen, from 43.5% to 46.9% in 
1999.66 This finding may also reflect that more female pharmacists are now willing 
to work in rural areas.  
 
The feminisation of pharmacy is believed to be a significant and positive dynamic as 
women in general provide a better patient-focused service than men.15 In addition, 
female pharmacists are generally younger than males. Both the 2002 and 2006 
surveys reported that none of the female pharmacists was more than 51 years of age 
compared to 40% of males. This finding is in line with the national survey in 199966 
where female pharmacists (mean 41.7 years) were substantially younger than male 
pharmacists (mean 50.0 years).66 Thus, with more and younger female pharmacists 
working in rural areas, the issue of the ageing pharmacist workforce in these areas 
may no longer be a concern. However, it is believed that female pharmacists tend to 
not work full-time due to family commitments.14, 15, 59, 66 This problem is more 
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prominent in rural areas where a general shortage of pharmacists living in these areas 
results in a minimal chance of having two or more female pharmacists living in a 
particular area who are prepared to share one full-time position.59 Female 
pharmacists are also reported to be less likely to purchase pharmacies, and this may 
raise the issue of the sustainability of local pharmacies.14, 59  
 
About 10% of WA rural pharmacists in the 2002 survey did not take part in any CPE 
over the past year, and this had improved slightly in 2006. These rural figures, 
however, were lower than the national survey (2002)5, where only 3.1% of 
Australia’s community pharmacies (urban and rural) were not involved in any CPE 
during the past year. Access to CPE could be a problem in rural areas due to the 
remoteness of the practice, and also the difficulty in finding a relief pharmacist, for 
attending CPE usually requires taking time off work. On the other hand, rural 
pharmacists may be required to provide a wide range of services,7-9 and CPE could 
be seen as a critical tool for acquiring the skills to deliver these services. Research 
based on the National Pharmacy Database Project (2002)5 demonstrated that 
pharmacies with higher CPE involvement were more likely to be offering EPS, 
particularly diabetes and hyperlipidaemia services. Thus, Australia’s national bodies 
should further develop electronic, more accessible, practical and efficient forms of 
CPE for pharmacists residing in rural and remote areas.5 The forms developed, 
however, should not neglect the importance of pharmacists interacting with their 
peers.  
 
 
5.3.  Pharmacy Characteristics 
There was an even distribution of rural pharmacies located in “smaller towns” 
(PhARIA 4 to 6), and “larger towns” (PhARIA 1 to 3) in both surveys. The 2006 
survey also reported that the majority of pharmacies were located as stand alone or as 
part of strip shopping centres.  
 
The estimated mean of the turnovers of WA rural pharmacies in 2002 (after being 
adjusted) was comparable to the 2006 figure. However, the 2002 figure ($1.71 
million – without adjustment) was lower than the national figure (2002)5, which 
 Chapter 5: Discussion 43
showed an estimate turnover of  $1.84 million. This may relate to fewer prescriptions 
being dispensed in WA rural pharmacies compared to the national figure (2002)73. 
The percentages of WA rural pharmacies that dispensed more than 800 prescriptions 
per week in 2002 and 2006 surveys were 41.6% and 41.2%, respectively. In 
comparison, the national figure (2002)73 showed 53.5% of Australia’s pharmacies 
(rural and urban) dispensed more than 800 prescriptions weekly, and it was noted 
that more than 60% of pharmacy income was generated from dispensing 
prescriptions.  
 
About one-quarter of WA rural pharmacies had customer numbers of more than 1500 
per week in 2006. This is not directly comparable to the 2002 figure, since different 
categories were included in the question. It was reported that 31.7% of WA rural 
pharmacies in 2002 had customer numbers of more than 1400 per week, which was 
comparable to the national figure (2002)73 of 35.1% of Australia’s pharmacies. 
Similar days and hours of opening were reported for WA rural pharmacies in 2002 
and 2006. These were comparable to the national figure (2002)5, where Australia’s 
pharmacies (urban and rural) opened 52 hours (median) per week. Considering the 
shortage of pharmacists in rural areas, this may be an indication that rural 
pharmacists worked longer hours than their urban counterparts.  
 
Less than half of the pharmacies in 2002 were QCPP-accredited, but this had 
doubled in 2006. This is a positive finding since accreditation requires compliance 
with minimum standards of pharmacy facilities and staff training.75 Thus, 
membership of the national QCPP could be seen as an indicator of the quality of 
pharmacies in Australia. 
 
A large percentage of WA rural pharmacies in both surveys had an unenclosed 
counselling area, and a much lower percentage reported having a closed counselling 
area or a forward pharmacy. Less than 16% of WA rural pharmacies from both 
surveys had a forward pharmacy area. These figures were lower than the national 
figure (2002)73, where 27.3% of Australia’s pharmacies (rural and remote) reported 
having a forward pharmacy area. Forward pharmacy was first introduced in Australia 
in 1992 as one arm of the Pharmacy Extension Program (PEP), aiming to develop the 
counselling role of community pharmacists.76 Practising forward pharmacy requires 
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redesigning the area in front of the dispensary to allow a pharmacist to sit at a desk 
with a patient while he or she enters the prescription data into a dispensing computer, 
and reviews the patient’s prescribed or other medicines and other health-related 
matters. Consumers’ experiences of this model had been evaluated, and significant 
improvements were evident for frequency of counselling scores for a range of types 
of information received.19 Moreover, a study based on the national survey (2002)5 
reported that the inclusion of a forward pharmacy area was a significant predictor of 
an increased proportion of time being spent on patient consultation.73 Thus, the low 
uptake of forward pharmacy in WA rural pharmacy practice warrants closer 
consideration.  
 
More than half of WA rural pharmacies in 2002 belonged to banner groups, and this 
was not significantly different after four years. This is in line with the report in 2000 
that about half of the pharmacies in Australia had group membership.77 Banner 
groups offer support on administration and marketing issues that can relieve 
administrative tasks from pharmacists, allowing them to concentrate more on their 
professional role.77 A study from the National Pharmacy Database Project (2002)5 
reported that pharmacies that belonged to groups were much more likely to have 
higher sales figures, and also to provide greater consultation services to their 
consumers.58 In rural areas where financial and workforce problems are more 
pronounced, banner memberships may provide great benefits in terms of helping 
pharmacists to elevate their profile cost-effectively and save administrative time to 
enable more clinical activities.  
 
 
5.4.  Pharmacy Services 
5.4.1.  Prescription-related Activities 
Less than 50% of WA rural pharmacies reported they dispensed more than 800 
prescriptions per week in the 2002 and 2006 surveys. These were lower than the 
2002 national figure73, where 53.5% of Australia’s pharmacies (rural and urban) 
dispensed more than 800 prescriptions weekly. This may provide an indication that 
WA rural pharmacies dispensed fewer prescriptions than their urban counterparts. 
This is despite the fact that they served a larger population per pharmacy.71 
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The proportions of WA rural pharmacies that issued DAAs in aged care facilities 
(nursing homes and hostels) and in community settings, had not changed 
significantly over four years. However, the high percentage of pharmacies reported 
using DAAs for monitoring compliance in the 2002 and 2006 surveys, may indicate 
that DAAs have emerged as devices for enhancing compliance. These figures were 
only slightly lower than the percentage of pharmacies using verbal questioning or 
repeated prescriptions for monitoring compliance in both surveys. The use of DAAs 
in medication management has been supported by literature and survey evidence 
collated by Australian researchers.18 
 
Most pharmacies monitor patient responses to therapy by questioning patients or 
their carers. The use of methods other than verbal assessment to monitor the effects 
of prescribed therapy showed that the majority of WA rural pharmacies in both 
surveys used records of adverse effects in patients’ files. Monitoring adverse effects 
is important to anticipate or detect adverse reactions to drugs before they become 
inevitable or irreversible. Moreover, the use of clinical testing devices (such as 
weight scales, blood pressure and glucose meters) for monitoring had increased 
significantly from about 50% in 2002 to almost 80% in 2006. The use of clinical 
testing devices according to Australian standards78 may help to overcome the barrier 
to de-scheduling of prescribed medicines to “pharmacist-only” (S3) or “pharmacy” 
(S2) status. Hence, if clinical testing for monitoring purposes becomes widely and 
frequently performed in community pharmacies, then the case for widening the range 
of S3 and S2 products available in pharmacies would be strengthened.5 
 
About 60% of WA rural pharmacies performed supervised dosing for at least one of 
a range of drugs listed in the 2002 and 2006 surveys (methadone, buprenorphine, 
analgesics, benzodiazepines, and other psychotropics). Methadone was the most 
common drug being supervised by pharmacies in both surveys, with about half of the 
pharmacies providing this service. It was reported that 1,557 or 31% of Australia’s 
pharmacies in May 2000 were approved to participate in methadone maintenance 
programs involving the supervised dosing of methadone liquid.49 This implies a 
marked increase in participation rates by pharmacies in methadone maintenance 
programs since May 2000. Since October 2000, buprenorphine has been available as 
an alternative treatment for opioid dependence.79 This study showed that WA rural 
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pharmacies’ involvement in supervised dosing of buprenorphine tended to increase 
over time. The supervised dosing of methadone and/or buprenorphine is considered 
of importance in enhancing the effectiveness of opioid dependence treatment by 
increasing compliance and significantly improving retention, while lowering the risk 
of diversion.49  
 
Various written counselling aids were provided by WA rural pharmacies, and the 
figures had not significantly changed over time. More than 90% of pharmacies 
provided CMI for prescribed medications in the 2002 and 2006 surveys, and lower 
percentages were reported for written information produced by computer programs 
other than CMI, or other written or printed information. CMI and other written 
counselling, when available, should be seen as a supplement to verbal counselling.17 
Face-to-face counselling with the patient is the most acceptable way to legally clarify 
patients’ concerns and to avoid dispensing errors.17, 80 In the case of verbal 
counselling, both surveys reported that the majority of WA rural pharmacies 
provided counselling in an unenclosed counselling area. Less than half of the 
pharmacies used a closed counselling area, and a much lower percentage reported 
counselling patients in a forward pharmacy area. These corresponded with the 
findings that over 70% of WA rural pharmacies had an unenclosed area, and lower 
proportions of pharmacies had a closed counselling area or a forward pharmacy. 
 
5.4.2.  Medication Review Processes  
Pharmacies have been able from 1997 to engage and be remunerated for pharmacists 
accredited by the AACP or the Society of Hospital Pharmacists of Australia to 
perform comprehensive medication reviews in residential aged care facilities, and 
since 1 October 2001 to perform HMRs or DMMRs.45 A small percentage of WA 
rural pharmacies in 2002 performed medication reviews in residential aged care 
facilities, and this had not changed over four years. On the other hand, the percentage 
of pharmacies providing DMMRs had increased significantly from less than 30% in 
2002 to almost 60% in 2006. This was in line with the increasing proportion of 
pharmacies being registered as approved DMMRs providers, and having access to an 
AACP-accredited pharmacist. Registration to conduct medication reviews entitles 
such accredited pharmacists with special skills and knowledge to assist other health 
care professionals and to contribute to the care of residents or patients by ensuring 
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QUM.17 A survey of domiciliary medication reviews in Australia reported that in 
most cases, the rural GPs encouraged pharmacists to get involved in this process as 
the benefits for the patient have been established.81  
 
A low percentage of WA rural pharmacies in both surveys were involved in the 
Section 100 (S100) program. The S100 scheme was introduced in Australia in 
February 1999 in order to improve access to medicine for Indigenous people in 
designated remote areas. Under the scheme, Aboriginal Health Services (AHSs) in 
remote areas can order bulk supplies of Pharmaceutical Benefits Scheme (PBS) 
medications through a selected pharmacy, and distribute them directly, as needed, to 
patients.22 Thus, pharmacies are not involved in individual dispensing processes.  
Instead, pharmacists are intended to be involved at a systems level to support safe 
and legal medications management at the S100 sites.22 A survey of AHSs and 
pharmacies which participated in the S100 program indicated that, although 
community pharmacy have provided a good supply mechanism for medications in 
bulk to AHSs, there is a need in the AHS sector for training by pharmacists on 
medicines issues.23 An allowance has been provided for pharmacies providing 
support services to the S100 program, however, it has been suggested that this 
allowance is inadequate, and the uptake has been extremely low.23, 82 This may be 
compounded by a scarcity of pharmacists in rural and remote areas leading to issues 
of overwork.83 Hence, these issues need to be addressed to improve pharmacists’ 
involvement in ensuring QUM. 
 
5.4.3.  Preventive Services  
The rates of OTC agents issued and screening tests performed reflect the extent and 
level of prevention (mainly primary preventive) activities offered by WA rural 
pharmacies [Table 4.16 and Table 4.17]. Since rural populations have poorer health 
outcomes than urban populations and have less access to health services, preventive 
services are of great importance. In the 2002 and 2006 surveys, it was reported that 
more than 90% of WA rural pharmacies provided nicotine replacement, folic acid for 
pregnancy, calcium, or daily multivitamins for undiagnosed patients. Nicotine 
replacement has been recommended in the Royal Australian College of General 
Practitioners (RACGP) guidelines (2005)48 as an effective treatment for smoking 
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cessation. Tobacco smoking is one of the behavioural determinants of health that 
accounts for the greatest burden of disease in Australia. Estimates from the 2004 
National Drug Strategy Household Survey (NDSHS)3 indicated that around 2.9 
million Australians (17.4% of people aged 14 years and over) smoked tobacco daily, 
while people living in rural and remote areas were reported to be more likely to be 
smokers than those living in major cities1. Supplementation of 0.5 mg folic acid daily 
is suggested in all women planning to become pregnant to prevent neural tube 
defects in offspring.48 A diet high in calcium (1000-1500 mg/day) is indicated for 
preventing osteoporosis in women 45 years of age and men 50 years of age.48 
However, the preventive effects of OTC agents, especially vitamins, need to be 
carefully considered by pharmacy bodies in Australia. For instance, a randomised, 
double-blind, placebo-controlled trial found that a combined treatment of folic acid 
and B vitamins (B6 and B12) taken daily by persons with high cardiovascular risk did 
not lower mortality or incidence of vascular diseases and, therefore, should not be 
recommended.84  
 
The most common screening performed in WA rural pharmacies was blood pressure 
measurements, with more than 50% of pharmacies offering this service. The 
AusDiab Study found that in 1999-2000 the prevalence of high blood pressure in 
Australia was 28.6 per 100 people with 15.2 per 100 untreated and possibly 
undiagnosed.85 A high burden of cardiovascular disease and cardiovascular risk was 
found in those with untreated hypertension.86 Thus, early detection and appropriate 
treatment of hypertension are of importance in reducing cardiovascular disease rates 
in Australia. Less than 25% of WA rural pharmacies offered glucose tests in both 
surveys. The recent national guidelines (updated in 2005) have recommended the use 
of fasting plasma glucose testing, performed in a laboratory, for diabetes screening.87 
However, people living in rural areas may be a significant distance from a laboratory, 
and point-of-care glucose testing may have a useful role in screening for diabetes 
risk, yet the diagnosis of diabetes should still rely on confirmatory tests of plasma 
glucose in the laboratory.88 
 
Blood cholesterol tests were reported in less than 10% of WA rural pharmacies in 
both surveys. The lower rates of cholesterol screening in pharmacies may be due to 
legal or practical barriers to skin penetration, ignorance or resistance by clients or 
 Chapter 5: Discussion 49
their carers, or may be related to time or capital expense issues. The lower 
percentages of pharmacies providing bone density testing may be due to the fact that 
such testing is offered and promoted through community pharmacies across Australia 
at specific times. This service is organised by the Australian Bone Density Testing 
Centre and, hence, this test is provided by external staff.89  
 
Interestingly, the prevalence of WA rural pharmacies that provided weight testing 
had increased from less than 10% to almost 50%. This is in line with the finding that 
more pharmacies offered weight management services over four years. This may be 
due to the increase of the awareness, knowledge and/or skills of weight screenings in 
rural pharmacies, which is related to the introduction of a national program 
“Lifeweight” in March 2004. This coincided in Australia with the change in 
classification of orlistat, an effective weight management agent, from a medically 
prescribed (S4) to a “pharmacist-only” (S3) product in May 2004. National 
pharmacy bodies and the pharmaceutical manufacturer of orlistat have cooperated to 
promote a weight management program in a kit form for pharmacies. It includes a 
“Weight Category” package with electronic weight scales, anthropometric 
measurement tape, client record forms, an educational CDROM and support 
materials for clients and pharmacy assistants.90  
 
5.4.4.  Primary Health Care 
WA rural pharmacies provided a range of primary health care, as evidenced by all 
pharmacies in the 2002 and 2006 surveys were involved in self-medication, and 
assisting patients with their symptoms or health problems. More pharmacies in 2006 
issued printed information, including computerised CMI and Self Care cards, for 
non-prescribed medicines to their clients. This may be related to the increasing 
availability of CMI by this time, as the Pharmaceutical Society of Australia (PSA) 
recommended CMI to be provided for all prescribed and “pharmacist-only” 
medicines by 2004.17 A range of training programs and incentives that has been 
provided to promote and improve the effective use of CMI in pharmacy practice91, 
may also influence this positive finding. Moreover, the recent PSA guidelines have 
recommend that pharmacies should provide CMI leaflets to their customers since 
CMI is an official document prepared by the sponsor conveying brand-specific 
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medicine information. Other forms of written medicines information such as Self 
Care cards, however, could be provided only as a supplement to CMI in assisting 
consumers’ understanding of their condition or medication issues.92 
 
5.4.5.  Harm Minimisation Services 
Community pharmacies have an important role in minimising infections and other 
harm related events with drug misuse. The main harm reduction interventions have 
been the provision of methadone treatment and needle or syringe programs.49, 50 It 
was reported that more than 60% of the WA rural pharmacies in both surveys 
provided needle supply or exchange. This is in line with the finding that 50% of 
pharmacies in Australia offer sterile injecting equipment either by sale or through an 
exchange program to the estimated 100,000-175,000 regular or occasional injecting 
drug users.49 A comparison study of rural and metropolitan drug users in NSW 
demonstrated that rural pharmacies were being accessed more than their urban 
counterparts for obtaining clean injecting equipment. The researchers, however, 
noted that pharmacies typically can not provide the information, education and 
support that fixed site Needle and Syringe Programs (NSPs) offer.93  
 
Over 45% of the WA rural pharmacies provided methadone dosing, and this was not 
statistically significantly different over four years. These figures were similar to 
those reported for the provision of supervised dosing for methadone. It is known that 
the ability of pharmacists to dispense and supervise the consumption of methadone 
not only improves the flexibility and convenience of dosing, but also increases the 
treatment retention and prevents the diversion of methadone.49 Nevertheless, it was 
reported that in both surveys, small percentages of pharmacies had trained staff 
despite most of them receiving payments for harm minimisation services, including 
methadone. This may warrant further development of training programs in order to 
improve the pharmacy’s role in providing harm minimisation services for rural 
communities. 
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5.4.6.  Enhanced Pharmacy Services (EPS) 
WA rural pharmacies reported providing a range of EPS in 2002 and 2006 [Table 
4.22]. This was an addition to the extensive medication-related services recorded by 
pharmacies in both surveys.   
 
There were some inconsistencies between the high prevalence of certain risk factors 
and disorders in rural Australia and the rates of provision of corresponding EPS by 
rural pharmacies in WA. The National Health Priorities Areas (NHPAs) include 
asthma, mental health, cardiovascular health, cancer control, diabetes, injury 
prevention and control, arthritis and other musculoskeletal conditions.94 It is 
documented that the prevalence of cardiovascular diseases, diabetes, respiratory 
diseases, and other chronic conditions are higher in rural areas. This is related to the 
higher levels of health risk factors among rural populations such as smoking, obesity 
and physical inactivity.1-3,6 The 2002 survey, however, showed that less than 50% of 
WA rural pharmacies were offering some of the EPS that correspond to NHPAs and 
rural health issues (asthma, weight reduction, diabetes, hypertension, 
hyperlipidaemia). Only smoking cessation had a service percentage higher than 50%, 
and tended to increase over time.  
 
The provision of asthma, diabetes, hypertension, and hyperlipidaemia did not show 
significant changes over four years. However, the proportion of pharmacies, which 
provided weight management service, had increased from about 30% to almost 60%. 
Weight management was also ranked first as the service planned within a 12-month 
period, together with diabetes and geriatric care. The increasing uptake of weight 
management services in rural pharmacy practice is a positive finding, since about 
60% of Australian adults were either overweight or obese in 200495, and it is well 
documented that people living in rural areas are more likely to be overweight or 
obese1. This may relate to the substantial proportion of Indigenous populations living 
in these areas. Self-reported results from the 2004-05 National Aboriginal and Torres 
Strait Islander Health Survey (NATSIHS) indicated that, in each age group, 
Indigenous males and females tended to be obese compared to other Australians.96  
Despite the higher acceptance of weight management services in rural pharmacy 
practice, more pharmacies in 2006 reported having trained staff for the service. The 
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increase in pharmacies with staff trained and offering weight management in rural 
WA may be related to the introduction of a national program “Lifeweight” in March 
2004, which coincided with the change in classification of orlistat from a medically 
prescribed to a “pharmacist only” (S3) product in May 2004.90  
 
Given the low rates of some EPS relative to the rural health issues in both surveys, it 
is important to analyse what prevented and facilitated the involvement of rural 
pharmacies in EPS. In 2002, there was an even spread of factors considered as 
important facilitators in providing EPS such as allocation of study time, 
accreditation, clinical testing, and counselling area. The most common reported 
barriers to undertaking EPS involved either time constraints, a shortage of 
pharmacists, no extra remuneration, or the inability to find locums. After four years, 
the facilitators and barriers reported by WA rural pharmacies remained the same.  
 
Given the lack of time and a shortage of pharmacists as the major barriers in both 
surveys, comparisons were made for number of FTE pharmacists per WA rural 
pharmacy (PhARIA 2-6) in 2002 and 2006. This was calculated with an assumption 
that 1 FTE pharmacist worked for 51 hours per week, which was the median of 
opening hours per week in 2006. It was found that number of FTE pharmacists per 
WA rural pharmacy only increased slightly from 1.49 in 2002 to 1.66 in 2006. This 
indicates that the workforce issues still remained a problem in WA rural pharmacy 
practice and, hence, corresponds to the barriers reported in both survey. The similar 
number of FTE pharmacists in both surveys may be related to the trend of an 
increasing proportion of female pharmacists in 2006. While it is believed that female 
pharmacists tend to not work full-time,14, 15, 59, 66 the FTE pharmacists may not 
improve significantly with the increasing number of female pharmacists taken up 
rural practice. However, this may need a closer investigation in order to provide clear 
directions for the government and pharmacy bodies in addressing the shortage of 
pharmacists in rural areas. 
 
Research based on the National Pharmacy Database Project (2002)5 found that 
significant barriers to EPS were a perceived lack of confidence and the EPS not 
being seen as pharmacy practice. It was also noted that pharmacy and pharmacists’ 
characteristics such as the inclusion of closed counselling area and higher CPE, were 
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significant predictors for offering EPS.54 These findings may assist in designing 
programs aimed to improve the provision of EPS in rural areas.  
 
Moreover, promotion campaigns may play an important role in increasing the uptake 
of important services. For example, the introduction of the “Lifeweight” program90 
has been evident in increasing pharmacies’ involvement in weight testing and weight 
management services. Even wound care, which was a condition of low frequency, 
was reported in more than 40% of pharmacies in both the 2002 and 2006 surveys. Its 
high acceptance has demonstrated the success of the organised promotion and 
traditional nature of a service.97 Clearly, these findings show that a marked increase 
in the uptake of services can occur if support is provided. 
 
 
5.5. Study limitations  
This study has several limitations that are important to acknowledge. First, WA rural 
pharmacies involved in the 2002 survey were not exactly the same with those 
involved in the 2006 survey. In repeat cross-sectional studies, the initial and 
subsequent studies do not necessarily recruit the same individuals, since community 
and not individual changes are of interest. A series of cross-sectional studies have 
been used to investigate changes in practice over time.98 Second, the 2002 data of 
WA rural pharmacies were sourced from the national survey (2002)5, which was a 
census of PhARIA 2 to 6 and a 20% random sample of PhARIA 1 pharmacies. The 
20% random sample was based on the high number of PhARIA 1 pharmacies. The 
2006 survey was a census sample of all WA rural pharmacies, including a small 
number of PhARIA 1 rurally located pharmacies. There was, therefore, a 
comparatively small under-representation of PhARIA 1 rurally located pharmacies in 
the 2002 survey. This, however, was not considered as a major issue in this study, 
since the chi-square test of the percentage of WA rural pharmacies across PhARIA 
(PhARIA 1 to 6) against year of study (2002 and 2006) showed no significant 
difference. 
 
Third, this study was based on self-reported data that may be subjected to bias as a 
result of responders knowingly misinterpreting activities, or as a result of unwittingly 
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poor memory or misconceptions regarding the actual state of affairs.98 However, 
several methods have been applied to ensure the validity of data collected:                
(i) pharmacists were assured about the confidentiality, and informed that the study 
was conducted for the benefit of rural pharmacy practice, all of which may 
encourage pharmacists in providing valid responses; (ii) questionnaires should be 
completed by pharmacists, who have an adequate knowledge of the pharmacy; and 
(iii) the questionnaire was carefully constructed and designed. The questionnaire 
used in 2006 survey was designed based on that used in the Australia’s National 
Pharmacy Database Project (2002)5. The 2002 questionnaire was constructed in 
consultation with a wide range of specialist pharmacists, and was examined and 
tested by academic, administrative, specialist and practicing pharmacists throughout 
the country (PhARIA 1 to 6). A focus group of pharmacists was conducted to gain 
practical feedback on the questionnaire. Fourth, changes in the wording of some 
questions within the 2006 questionnaire from those within the national survey 
(2002)5 questionnaire may have limited the scope of the comparisons between 2002 
data and 2006 data. However, these changes were made to suit the specific rural 
situations. Lastly, this study provides broader information on the proportions of 
pharmacies performing a range of services, without taking into account detailed data 
on frequency and quality of services. Thus, further research focused on gaining 
detailed data of particular services is noteworthy. 
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6.  CONCLUSIONS 
 
 
This study provides information on the changes in WA rural pharmacy practice 
between 2002 and 2006. The pharmacist characteristics were not significantly 
different after four years with regard to age, gender, year of registration, highest 
qualification, CPE, and their position in the pharmacy. However, there was a trend of 
an increasing female proportion of the pharmacy workforce that may influence rural 
pharmacy practice.  
 
Similar figures of pharmacy characteristics in 2002 and 2006 were reported in 
relation to PhARIA location, setting of pharmacy, group membership, the inclusion 
of counselling areas, method of operation, trading hours and annual turnover. Only 
QCPP accredited-pharmacies had increased significantly, which may imply the 
improved quality of WA rural pharmacies over time.  
 
In both surveys, WA rural pharmacies were reported as providing a wide range of 
services, including prescription-related activities (DAAs, monitoring, supervised 
dosing, and counselling activities), medication review processes, preventive services, 
primary health care, harm minimisation services (particularly methadone and/or 
buprenorphine dosing, and needle supply or exchange), and EPS. However, several 
significant differences were reported across the two surveys. More pharmacies 
provided clinical testing for monitoring, and printed information for non-prescribed 
medicines. A higher percentage of pharmacies performed DMMRs, which was in 
line with the increasing proportion of pharmacies being registered as approved 
DMMRs, and having access to an AACP-accredited pharmacist. There were rapid 
increases in weight testing and weight management services. Smoking cessation was 
offered by more than 50% the pharmacies, and had tended to increase. 
Disappointingly, other EPS (asthma, diabetes, hypertension, hyperlipidaemia), which 
correspond with Australia’s health priorities and rural needs, were reported by low 
percentage of pharmacies in both surveys. A shortage of pharmacy workforce had 
remained a problem, as evidenced by the similar figures of FTE pharmacists per WA 
rural pharmacy across the two surveys. Thus, government and pharmacy bodies 
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should take these issues into consideration when designing new programs aimed to 
increase access to pharmacy practice. Moreover, support for the important services is 
clear if they are to be taken up by the profession. 
 
This study also highlights several issues that may warrant closer consideration, 
including CPE involvement, low uptake of forward pharmacy, and low participation 
in the S100 scheme. In improving rural pharmacists’ involvement in CPE, the 
government and pharmacy bodies should further develop more accessible, practical 
and efficient forms of CPE, which also consider the need of pharmacists to interact 
with their peers. The low uptake of forward pharmacy in rural pharmacy practice 
may require further research on the facilitators and barriers of applying this model in 
rural pharmacy practice and, thus, provide assistance for future interventions. The 
government and pharmacy bodies should also address the issue of the low 
participation in the S100 scheme by dealing with barriers such as the inability to 
access locum pharmacists, and the lack of time to provide support services. 
Pharmacists’ involvement in providing support and advice on medication 
management in AHS sites is important in ensuring the quality use of medicines.  
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Appendix 2: Questionnaire – Rural Pharmacy Services (2006) 
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SECTION A:  Respondent pharmacist details 
 
1. Gender. Please tick (√ )                                                 
                     
        
 
2. Age. Please tick (√ )                                                                         
 
 
 
 
 
3. In which year did you first obtain Australian registration as a pharmacist (any 
category) in any State or Territory? 
 
4. a) Please tick (√ ) where your secondary schooling was done. 
 
 
b) Please tick (√ ) where you resided when you studied at secondary 
school.   
 
   
 
5. a) Please tick (√ ) your highest qualification in pharmacy. 
 
 
 
 
 
 
 
 
 
        b) Please tick (√ ) the average number of hours you spent each month 
        on Continuing Pharmacy Education activities in the last 12 months. 
 
 
 
 
 
 
 
c) Please tick (√) the percentage of your involvement in the following Continuing Pharmacy Education (CPE) 
% CPE time involvement 0 – 20 % 21 – 40 % 41 – 60 % 61 – 80% 81 – 100 % 
Conferences      
Course/lectures (seminars)      
Journals/ personal reading      
Online      
Questionnaires in professional journals      
Other (specify)  
______________________________ 
     
 
6. Please tick (√ ) which one of the following best describes your position 
in this pharmacy. 
 
 
 
 
Male  
Female  
21 - 30  
31 - 40  
41 - 50  
51 - 60  
61+  
    
Rural   
Metropolitan   
Rural   
Metropolitan   
Diploma  
B Pharm  
M Pharm  
PhD  
Other (specify)  
___________________  
None  
1 to 5 hours  
6 to 10 hours  
11 to 20 hours  
More than 20 hours  
Sole proprietor  
Partner proprietor  
Salaried manager  
Pharmacist in charge  
Locum pharmacist  
Consultant pharmacist  
Employee pharmacist  
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SECTION B:  Pharmacy Services 
 
Prescription related activities  
7. a)   Please tick (√ ) the average number of prescription items dispensed in this pharmacy in a typical period of 
seven days (one week).  
Prescriptions per week 0 to 300 301 to 800 801 to 1,200 1,201 to 2,000 2,001 to 3,000 3,001 or more 
Total       
 
b)   Please tick (√ ) the average number of patients in the following categories who order prescribed drugs in a 
typical period of seven days in this pharmacy. 
Category of order None  at all 
Less than 1 
per week 
1 to 5 
per week 
6 to 10 
per week 
11 to 20 
per week 
21 or more 
per week 
Mail (post)       
Facsimile       
Telephone       
Other (specify)  
__________________ 
      
 
c)   Please tick (√ ) the average number of patients in the following categories who were delivered prescribed drugs 
in a typical period of seven days in this pharmacy. 
Category of delivery 
None at 
all 
Less than 1 
per week 
1 to 5 
per week 
6 to 10 
per week 
11 to 20 
per week 
21 or more 
per week 
Mail       
Courier       
Depot       
Other (specify)  
_________________       
 
8. Please tick (√ ) the average number of patients in a typical period of seven days in the following settings who 
received from this pharmacy prescription items packaged in dose administration aids or DAAs (eg. Webster-type, 
Dosette-type) 
Aged care or 
community setting 
None  
at all 
Less than 1 
per week 
1 to 20 
per week 
21 to 50  
per week 
51 to 100  
per week 
101 to 250 
per week 
251 or more 
per week 
Nursing home        
Hostel        
Community based 
patients 
       
Remote health clinics 
(specify)  
_________________ 
       
 
9. Please tick (√ ) the number of individual (different) patients who received the following drugs by supervised 
dosing in this pharmacy during a typical period of seven days. 
Drug groups dosed in 
pharmacies 
None 
per week 
Less than 1 
per week 
1 to 5 
per week 
6 to 10 
per week 
11 to 20 
per week 
21 or more 
per week 
Analgesics (specify) 
________________________ 
      
Benzodiazepines (specify) 
________________________ 
      
Buprenorphine       
Methadone       
Other psychotropic agents 
(specify) ________________ 
      
Other agents (specify) 
________________________ 
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10. Please tick (√ ) the number of patients in the past seven days who were declined prescription drugs for the 
following reasons. 
Reason for declining  
prescribed drugs 
None  
at all 
Less than 1 
per week 
1 to 2 
per week 
3 to 5 
per week 
6 to 10 
per week 
11 or more 
per week 
Inappropriate drug or dose, 
suspected interaction, or 
contraindication 
      
Suspected adverse effect       
Duplication, prescription defects       
 
11. Please tick (√ ) the estimated number of patients with prescription medications who fall into of the following 
counselling categories in this pharmacy during a typical working day. Forward pharmacy refers to a seated 
counselling area with dispensary computer. 
Verbal or written counselling None  at all 
Less than 1 
per day 
1 to 5 
per day 
6 to 10  
per day 
11 to 20 
per day 
21 or more 
per day 
Non-or-poor-English speaking 
patients 
      
CMI computerised       
Other computer produced 
information 
      
Other written or printed drug 
information 
      
Counselled or administered 
medicines in closed counselling 
area 
      
Counselled or administered 
medicines in private un-enclosed 
area 
      
Counselled or administered 
medicines in a forward pharmacy 
area 
      
Medication Assistance Service 
(MAS) or activity paid by health 
insurance 
      
Other (specify)  
_____________________________ 
      
 
12. Please tick (√ ) the estimated number of patients who received the following monitoring activities for compliance 
with their prescribed medications in this pharmacy during a typical period of seven days. 
Monitoring compliance None at all 
Less than 1 
per week 
1 to 10 
per week 
11 to 40 
per week 
41 to 80 
per week 
81 or more 
per week 
Monitor compliance by 
appropriate questions 
      
Monitor compliance by 
frequency of repeats 
      
Monitor with DAAs ( eg. 
Webster-type, Dosette-type) 
      
Other (specify)  
_____________________ 
      
 
13. Please tick (√ ) the estimated number of patients who received the following monitoring activities for  therapeutic 
and adverse effects of their prescribed medications in this pharmacy during a typical period of seven days. 
Monitoring therapeutic and adverse effects None at all 
Less than 1 
per week 
1 to 5  
per week 
6 to 10  
per week 
11 or more 
per week 
Clinical testing in pharmacy with devices such 
as weight scales, glucose meters, blood 
pressure meters, peak flow meters 
     
Laboratory test results to monitor medication 
effects 
     
Adverse reactions recorded in patient file (eg. 
drug allergies) 
     
Other (specify)  
_____________________________________ 
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14. Please tick (√ ) if there is a Silver Chain or Community Nursing post in your town. 
Yes  
No  
 
 If YES: 
a) Please tick (√ ) how often the pharmacy provides medications to the Silver Chain or Community Nursing post.  
None at all Less than 1 per week 
1 to 2 
per week 
3 to 5 
per week 
6 to 10 
per week 
11 or more 
per week 
      
 
b) Please tick (√ ) if the Silver Chain or Community Nursing post impact on the pharmacy’s service provision. 
      Please specify: 
_____________________________________________________________________ 
 
 
 
Medication review process 
15. a)   Please tick (√ ) if the pharmacy supplies medicines to patients in residential aged care facilities (eg. nursing 
homes, hostels) or private hospitals. 
Yes  
No  
 
b)   Please record the number of beds in the following locations supplied with medicines by this pharmacy. 
Type of external facility Beds supplied 
Nursing homes  
Hostels   
Private hospitals  
Other (specify)  
___________________________________ 
 
 
c)   Please tick (√ ) if this pharmacy is registered with the HIC as an approved Home Medicine Reviews (HMRs) or 
DMMRs Service Provider. DMMR refers to Domiciliary Medication Management Review, a term interchanged with 
HMR. 
Yes   
No  
Don’t know  
 
d)   Please tick (√ ) the number of patients in a typical month in 2006 involved in the following medication review 
processes in which this pharmacy participated. 
Medication review processes 
reimbused 
None 
at all 
Less than 1 
per month 
1 to 10  
per month 
11 to 50  
per month 
51 to 100 
per month 
101 to 200 
per month 
201 or more 
per month 
Home Medicine Review (HMRs) 
or DMMRs 
       
Medication Management Review 
in residential aged care facilities 
       
Enhanced Primary Care (EPC) 
Multidisciplinary Care Plan 
       
Enhanced Primary Care (EPC) 
Case Conference 
       
Enhanced Primary Care (EPC) 
Case Health Assessment 
       
Section 100 medicine access 
scheme for aborigines 
       
Other form of medication review 
(specify)  
__________________________ 
       
 
 
 
 
Yes  
No  
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e)   Please tick (( ) if this pharmacy has access to an Australian Association of Consultant Pharmacy (AACP) 
accredited pharmacists. 
Yes   
No  
Don’t know  
 
f)   Please tick (( ) which of the following positions the AACP accredited pharmacist occupies in this pharmacy. 
Proprietor  
manager  
Employee pharmacist full-time  
Employee pharmacist part-time  
Consultant or contracted pharmacist  
Other (specify)  
________________________________ 
 
 
 
Health promotion 
16. Please tick (( ) the estimated number of clients in the last seven days who received one of the following agents 
initiated in this pharmacy by a pharmacist and not prescribed by a doctor. 
Preventive activities with 
non-prescribed medicines 
None  
at all 
Less than 1 
per week 
1 to 2 
per week 
3 to 5 
per week 
6 to 10 per 
week 
11 to 20 
per week 
Over 20 
per week 
Nicotine replacement therapies        
Aspirin (100 mg or less per day) 
for the primary or secondary 
prevention of coronary heart 
disease 
       
Iron supplementation to prevent 
anaemias in females        
Folic acid in early pregnancy to 
prevent neural-tube defects in 
offspring 
       
Calcium products to prevent 
osteoporosis        
Daily multivitamins to prevent 
suspected nutritional deficiency        
Other (specify)  
________________________ 
________________________ 
       
 
17. Please tick (( ) the estimated average number of each of the following tests performed to screen 
undiagnosed patients during a typical period of 30 days in this pharmacy 
Clinical testing to screen 
undiagnosed patients 
None  
at all 
Less than 1 
per month 
1 to 2 
per month 
3 to 10 
per month 
11 to 20 
per month 
21 or more 
per month 
Anthropometric tests (eg. body 
weight, height, and waist 
circumference) 
      
Blood cholesterol testing       
Blood pressure testing       
Blood glucose testing       
Bone density testing       
Pregnancy testing       
Other (specify)  
________________________ 
________________________ 
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Primary health care including pharmacy (S2) and pharmacist-only (S3) medicines  
18. Please tick (√ ) the average number of clients who received the following services in a typical working day in 
this pharmacy. 
Primary health care activities in this pharmacy 
(excludes prescription medicines) 
Less than 1 
per day 
1 to 5 
per day 
5 to 10 
per day 
11 to 20 
per day 
21 or more 
per day 
Total who asked for S2 and S3s by name  
(i.e. self medication) 
     
Total who received assistance with symptoms, 
health problems, or questions 
     
Clients issued computerised CMIs, printed 
information (e.g. Self Care card) 
     
Clients referred to GP with ailments      
Clients referred to other health practitioners      
Other (specify) 
______________________________________ 
     
 
 
Harm minimisation or harm reduction activities 
19. Please tick (√ ) the estimated average number of clients provided with each of the following harm 
minimisation or harm reduction activities during a typical working day. 
Harm minimisation or  
reduction activity 
None  
at all 
Less than 1 
per day 
1 to 5 
per day 
6 to 10 
per day 
11 to 20 
per day 
21 or more 
per day 
Methadone dosing       
Buprenorphine dosing       
Naltrexone dispensed       
Needle exchange or supply       
Benzodiazepine contracts or 
prescriber arrangements to prevent 
diversion and misuse of drugs of 
dependence 
      
Other harm minimisation activity 
(specify)  
_____________________________ 
_____________________________ 
      
 
 
Complementary therapies 
20. Please tick (√ ) the estimated average number of clients referred to a practitioner or provided with the 
following complementary therapies by this pharmacy in a typical period of 30 days 
Complementary therapies  
referred or provided 
None  
at all 
Less than 1 
per month 
1 to 5 
per month 
6 to 10 
per month 
11 to 30 
per month 
31 or more  
per month 
Acupuncture       
Aromatherapy       
Chiropractic       
Homeopathy       
Hypnosis       
Iridology       
Meditation       
Naturopathy       
Reflexology       
Massage       
Spiritual healing       
Other (specify)  
______________________ 
______________________ 
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Enhanced pharmacy services  
21. Please tick (√ ) the following categories of enhanced pharmacy services over and above routine practice that 
this pharmacy offers or plans to offer. 
Offers now Category of  
enhanced pharmacy service 
Does not 
offer 
Specially trained or 
accredited pharmacist 
or non-pharmacist 
Offers at  
no charge 
Receives 
payment for 
Plan to 
offer in 
12 months 
Aboriginal health services      
Anticoagulation      
Asthma      
Community education, structured      
Community clinic services with 
nurse 
     
Diabetes      
Drug level monitoring/ kinetic dosing      
Harm reduction including 
methadone 
     
Geriatric care      
Herbal medicines/nutritional 
supplement counselling 
     
Hyperlipidaemia      
Hypertension      
Naturopathy      
Smoking cessation      
Weight reduction      
Wound care      
Other (specify) 
_____________________________ 
_____________________________ 
     
SECTION C: Barriers and Facilitators  
 
22. Please tick (√ ) the extent to which you agree or disagree that the following are barriers to this pharmacy 
implementing enhanced pharmacy services listed in question 21. 
Barriers to enhanced pharmacy services 
 in this pharmacy 
Strongly 
disagree Disagree Unsure Agree 
Strongly 
agree 
Shortage of time for pharmacist      
Shortage of pharmacists      
Customer’s won’t pay      
Unable to get locum cover for emergencies      
Lack of appropriate knowledge/skills by 
pharmacists      
Lack of confidence by pharmacy staff      
It is not felt by pharmacists to be part of their job      
There is no extra remuneration for it      
Would impair working relationships with local 
general medical practitioners (GP’s)      
Lack of opportunity to meet with local GP’s or 
other health workers      
GP’s do not recognise pharmacists’ skills in 
enhanced pharmacy services      
Poor retention rates of employees      
Other (specify) 
______________________________________      
 
23. Please tick (√ ) the extent to which you disagree or agree that the following will facilitate this pharmacy 
implementing the enhanced pharmacy services listed in Question 21. 
Facilitators of enhanced pharmacy services 
 in this pharmacy 
Strongly 
disagree Disagree Unsure Agree 
Strongly 
agree 
Access to detailed patient notes      
Designated closed counselling area      
Designated clinical resting area      
Appointment system      
Accreditation for specific activity      
Dedicated study time for pharmacist      
Other (specify)  
________________________________________      
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SECTION D: Pharmacy Characteristics 
  
24. a) Location of this pharmacy by postcode. 
    
 
b) Please tick (√ ) which one of the following best describes the setting of this pharmacy. 
Stand alone or strip shopping centre  
Shopping mall complex  
Medical centre  
Hospital  
Other (specify) ______________________________________  
 
25. Please record the total hours in each day this pharmacy is open. 
 Monday Tuesday Wednesday Thursday Friday Saturday Sunday 
Hours        
 
26. Please record or estimate as accurately as possible the area of each of the following sections in this 
pharmacy. If a certain area is not applicable then please enter a value of zero (0). 
Dispensary area m2 
Schedule area (for S2s and S3s) m2 
Forward pharmacy area (seated counselling area with 
dispensary computer) m
2 
Private un-enclosed counselling/dosing area m2 
Closed counselling/dosing area m2 
Retail area m2 
Storeroom, office, etc m2 
Other (specify) ______________________________________ m2 
Total area of premises 
 
m2 
 
27. Please tick (√ ) which one of the following describes this pharmacy’s group membership. 
Not in a group  
Amcal  
Chem Mart  
Friendly Societies  
Guardian  
Soul Pattison  
Other group (specify)  
___________________________________________________ 
 
 
28. Please tick (√ ) the QCPP status of this pharmacy. QCPP refers to Quality Care Pharmacy Program. 
Not yet registered for QCPP  
Partially completed QCPP accreditation  
Completed but not yet accredited  
QCPP accredited  
Re-accredited  
Other (specify)  
___________________________________________________ 
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29. a)   Please tick the method of operation in this pharmacy. 
Owner operated   
Partner operated  
Manager operated  
Other (specify)  
_____________________________________________ 
 
 
b)   Please tick (√ ) if this pharmacy has a non-pharmacist retail manager. 
Yes  
No  
 
30. Please record the number of current staff or contractors (including yourself) working in this pharmacy and 
their hours worked in a typical period of seven days. Please include zero (0) where there is no time spent on 
certain activity 
% of time spent in 
Pharmacy staff Full time (number) 
Part time 
and casuals 
(number) 
Total hours 
per week 
Dispensary 
(no patient 
contact) 
Clinical, 
patient care or 
counselling 
Administration 
work 
Proprietor/s       
Pharmacist manager       
Consultant pharmacist       
Other pharmacist staff       
Non-pharmacist manager 
(retail) 
      
Dispensary assistant / 
Pharmacy technician 
      
Non-pharmacist clerical 
or administration 
      
Other non-pharmacist 
staff 
      
Complementary or other 
health practitioners 
(Please specify)  
___________________ 
      
Total    
 
31. Please tick (√ ) the average total number of customers per week. Please include patients in hospitals and 
aged care facilities serviced by this pharmacy. 
0 – 500 501 – 1,000 1,001 – 1,500 1,501 – 2,000 2,001 – 3,000 3,001 or more 
      
 
32. a)   Please tick (√ ) the estimated annual turnover of this pharmacy. 
Total turnover 
(total pharmacy and other income) <$1m $1-1.5m $1.5-2m $2-3m $3-4m $4-6m $6-8m >8m 
         
 
b)   Please complete details of the sales/ turnover per year for each of the following categories. If not known 
for any category, then please estimate. 
Total prescription sales (incl. Safety Net and private prescriptions) ______   % turnover 
S2 and S3 medicines ______   % turnover 
Herbal products and vitamins sales ______   % turnover 
Medical aids and medical appliances / equipment (home health care) ______   % turnover 
  
 
THE END ~ THANK YOU 
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Appendix 3: List of WA Rural Pharmacies (2006) 
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Appendix 4: Cover Letter and Follow-up Letters  
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